var title_f5_32_5632="Elbow posterior lateral view";
var content_f5_32_5632=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=EM%2F60057&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=EM%2F60057&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Normal elbow, AP view",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 342px; height: 540px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Bruce C Anderson, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f5_32_5632=[""].join("\n");
var outline_f5_32_5632=null;
var title_f5_32_5633="Prurigo nodularis 1";
var content_f5_32_5633=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=DERM%2F53475&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=DERM%2F53475&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Prurigo nodularis",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 432px; height: 324px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Discrete, excoriated nolules on the leg of a patient with nodular prurigo.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: www.visualdx.com. Copyright Logical Images, Inc.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f5_32_5633=[""].join("\n");
var outline_f5_32_5633=null;
var title_f5_32_5634="Submucosal rectal abscess";
var content_f5_32_5634=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=SURG%2F78125&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=SURG%2F78125&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 485px\">",
"   <div class=\"ttl\">",
"    Submucosal rectal abscess",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 465px; height: 400px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    This figure illlustrates the palpation of an abscess in the anal canal by digital examination. This procedure should be performed for every patient with an abscess and/or an anal rectal fistula.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f5_32_5634=[""].join("\n");
var outline_f5_32_5634=null;
var title_f5_32_5635="AGEP 1";
var content_f5_32_5635=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=DERM%2F86911&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=DERM%2F86911&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 524px\">",
"   <div class=\"ttl\">",
"    Acute generalized exanthematous pustulosis (AGEP)",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 504px; height: 378px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Typical flexural accentuation of AGEP",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: www.visualdx.com. Copyright Logical Images, Inc.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f5_32_5635=[""].join("\n");
var outline_f5_32_5635=null;
var title_f5_32_5636="Dyshidrotic eczema large bullae";
var content_f5_32_5636=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=DERM%2F83007&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=DERM%2F83007&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 524px\">",
"   <div class=\"ttl\">",
"    Dyshidrotic eczema with large bullae",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 504px; height: 378px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: www.visualdx.com. Copyright Logical Images, Inc.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f5_32_5636=[""].join("\n");
var outline_f5_32_5636=null;
var title_f5_32_5637="Triamcinolone (nasal): Drug information";
var content_f5_32_5637=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"1\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"drugTitle\">",
"   Triamcinolone (nasal): Drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   (For additional information",
"   <a class=\"drug drug_patient\" href=\"UTD.htm?16/10/16548?source=see_link\">",
"    see \"Triamcinolone (nasal): Patient drug information\"",
"   </a>",
"   and",
"   <a class=\"drug drug_pediatric\" href=\"UTD.htm?15/56/16260?source=see_link\">",
"    see \"Triamcinolone (nasal): Pediatric drug information\"",
"   </a>",
"   )",
"   <br/>",
"   For abbreviations and symbols that may be used in Lexicomp (",
"   <a class=\"graphic graphic_table\" href=\"UTD.htm?23/39/24183\">",
"    show table",
"   </a>",
"   )",
"   <div class=\"list ubnlist drugH1Div drugBrandNames\" id=\"F9606519\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: U.S.",
"    </span>",
"    <ul>",
"     <li>",
"      Nasacort&reg; AQ",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"list cbnlist drugH1Div drugBrandNames\" id=\"F9606520\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: Canada",
"    </span>",
"    <ul>",
"     <li>",
"      Nasacort&reg; AQ;",
"     </li>",
"     <li>",
"      Trinasal&reg;",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ex_sect_xr thclist drugH1Div drugBrandNames\" id=\"F9608610\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pharmacologic Category",
"    </span>",
"    <ul>",
"     <li>",
"      Corticosteroid, Nasal",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"block doa drugH1Div\" id=\"F9606717\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Adult",
"    </span>",
"    <p style=\"text-indent:0em;margin-left:0em;text-align:justify;display:inline\">",
"     <b>",
"      Allergic rhinitis (perennial or seasonal):",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <i>",
"      Nasal spray:",
"     </i>",
"     220 mcg/day as 2 sprays in each nostril once daily; once symptoms controlled reduce to 110 mcg/day",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <i>",
"      Nasal inhaler:",
"     </i>",
"     Initial: 220 mcg/day as 2 sprays in each nostril once daily; may increase dose to 440 mcg/day (given once daily or divided and given 2 or 4 times/day)",
"    </p>",
"   </div>",
"   <div class=\"block dop drugH1Div\" id=\"F9606716\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Pediatric",
"    </span>",
"    <p>",
"     (For additional information",
"     <a class=\"drug drug_pediatric\" href=\"UTD.htm?15/56/16260?source=see_link\">",
"      see \"Triamcinolone (nasal): Pediatric drug information\"",
"     </a>",
"     )",
"    </p>",
"    <p style=\"text-indent:0em;margin-left:0em;text-align:justify;display:inline\">",
"     <b>",
"      Allergic rhinitis (perennial or seasonal):",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <i>",
"      Nasal spray:",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Children 2-5 years: 110 mcg/day as 1 spray in each nostril once daily (maximum: 110 mcg/day)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Children 6-11 years: Initial: 110 mcg/day as 1 spray in each nostril once daily; may increase to 220 mcg/day as 2 sprays in each nostril if response not adequate; once symptoms controlled may reduce to 110 mcg/day",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Children &ge;12 years: Refer to adult dosing.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <i>",
"      Nasal inhaler:",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Children 6-11 years: Initial: 220 mcg/day as 2 sprays in each nostril once daily",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Children &ge;12 years: Refer to adult dosing.",
"    </p>",
"   </div>",
"   <div class=\"block doe drugH1Div\" id=\"F9606718\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Geriatric",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Refer to adult dosing.",
"    </p>",
"   </div>",
"   <div class=\"block foc drugH1Div\" id=\"F9606843\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosage Forms: U.S.",
"    </span>",
"    <p style=\"text-indent:0em;text-align:justify;display:inline\">",
"     Excipient information presented when available (limited, particularly for generics); consult specific product labeling.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Suspension, intranasal, as acetonide [spray]: 55 mcg/inhalation (16.5 g)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Nasacort&reg; AQ: 55 mcg/inhalation (16.5 g) [chlorofluorocarbon free; contains benzalkonium chloride; 120 actuations]",
"    </p>",
"   </div>",
"   <div class=\"block geq drugH1Div\" id=\"F9606563\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Generic Equivalent Available: U.S.",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Yes",
"    </p>",
"   </div>",
"   <div class=\"block adm drugH1Div\" id=\"F9606775\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Administration",
"    </span>",
"    <p style=\"text-indent:0em;margin-left:0em;text-align:justify;display:inline\">",
"     Shake well prior to use. Gently blow nose to clear nostrils.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Nasacort&reg; AQ: Prime prior to first use, by shaking contents well and releasing 5 sprays into the air. If product is not used for more than 2 weeks, reprime with 1 spray.",
"    </p>",
"   </div>",
"   <div class=\"block use drugH1Div\" id=\"F9606564\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Use",
"    </span>",
"    <p style=\"text-indent:0em;margin-left:0em;text-align:justify;display:inline\">",
"     Management of seasonal and perennial allergic rhinitis",
"    </p>",
"   </div>",
"   <div class=\"block usu drugH1Div\" id=\"F14225240\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Use - Unlabeled",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Adjunct to antibiotics in empiric treatment of acute bacterial rhinosinusitis (ABRS) (Chow, 2012)",
"    </p>",
"   </div>",
"   <div class=\"block mst drugH1Div\" id=\"F9606497\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Medication Safety Issues",
"    </span>",
"    <div class=\"collapsible\">",
"     <span class=\"collapsible-title\">",
"      Sound-alike/look-alike issues:",
"     </span>",
"     <div class=\"collapsible-wrap\">",
"      <p style=\"text-indent:-2em;margin-left:4em;\">",
"       Nasacort&reg; may be confused with NasalCrom&reg;",
"      </p>",
"     </div>",
"    </div>",
"    <div class=\"collapsible\">",
"     <span class=\"collapsible-title\">",
"      Other safety concerns:",
"     </span>",
"     <div class=\"collapsible-wrap\">",
"      <p style=\"text-indent:-2em;margin-left:4em;\">",
"       TAC (occasional abbreviation for triamcinolone) is an error-prone abbreviation (mistaken as tetracaine-adrenaline-cocaine)",
"      </p>",
"     </div>",
"    </div>",
"   </div>",
"   <div class=\"block ars drugH1Div\" id=\"F9606591\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Adverse Reactions Significant",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     &gt;10%:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Central nervous system: Headache (2% to 51%)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Respiratory: Pharyngitis (5% to 25%)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     1% to 10%:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Cardiovascular: Facial edema (1% to 3%)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Central nervous system: Pain (1% to 3%)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Dermatologic: Photosensitivity (1% to 3%), rash (1% to 3%)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Endocrine &amp; metabolic: Dysmenorrhea (&ge;2%)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Gastrointestinal: Taste perversion (5% to 8%), dyspepsia (3% to 5%), abdominal pain (1% to 5%), nausea (2% to 3%), diarrhea (1% to 3%), oral moniliasis (1% to 3%), toothache (1% to 3%), vomiting (1% to 3%), weight gain (1% to 3%), xerostomia (1% to 3%)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Genitourinary: Cystitis (1% to 3%), urinary tract infection (1% to 3%), vaginal moniliasis (1% to 3%)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Local: Nasal burning (&ge;2%; transient), nasal stinging (&ge;2%; transient)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Neuromuscular &amp; skeletal: Back pain (2% to 8%), bursitis (1% to 3%), myalgia (1% to 3%), tenosynovitis (1% to 3%)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Ocular: Conjunctivitis (1% to 4%)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Otic: Otitis media (&ge;2%)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Respiratory: Sinusitis (2% to 9%), cough (&le;8%), epistaxis (&le;5%), bronchitis (children 3%), chest congestion (1% to 3%), asthma (&ge;2%), rhinitis (&ge;2%)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Miscellaneous: Flu-like syndrome (2% to 9%), voice alteration (1% to 3%), allergic reaction (&ge;2%), infection (&ge;2%)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     &lt;1% (Limited to important or life-threatening): Anaphylaxis, blood cortisol decreased, bone mineral density loss (rare; prolonged use), cataracts, dizziness, dry throat, dyspnea, fatigue, glaucoma, growth suppression, hoarseness, hypersensitivity, insomnia, intraocular pressure increased, nasal septum perforation, oral candidiasis, osteoporosis (rare; prolonged use), pruritus, sneezing, throat irritation, urticaria (rare), wheezing, wound healing impaired",
"    </p>",
"   </div>",
"   <div class=\"block coi drugH1Div\" id=\"F9606570\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Contraindications",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Hypersensitivity to triamcinolone or any component of the formulation",
"    </p>",
"   </div>",
"   <div class=\"block war drugH1Div\" id=\"F9606571\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Warnings/Precautions",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      <i>",
"       Concerns related to adverse effects:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Adrenal suppression: When used at excessive doses, may cause hypercorticism or suppression of hypothalamic-pituitary-adrenal (HPA) axis, particularly in younger children or in patients receiving high doses for prolonged periods. HPA axis suppression may lead to adrenal crisis. Withdrawal and discontinuation of a corticosteroid should be done slowly and carefully. Particular care is required when patients are transferred from systemic corticosteroids to inhaled products due to possible adrenal insufficiency or withdrawal from steroids, including an increase in allergic symptoms.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull;	Delayed wound healing: Avoid use in patients with recent nasal septal ulcers, nasal surgery, or nasal trauma until healing has occurred.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Immunosuppression: Prolonged use of corticosteroids may increase the incidence of secondary infection, mask acute infection (including fungal infections), prolong or exacerbate viral infections, or limit response to vaccines. Exposure to chickenpox should be avoided; corticosteroids should be used with caution, if at all, in patients with ocular herpes simplex, latent tuberculosis, and/or TB reactivity, or in patients with untreated fungal, viral, or bacterial infections.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Local nasal infections: Localized",
"     <i>",
"      Candida albicans",
"     </i>",
"     infections of the nose and/or pharynx may occur (rarely).",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      <i>",
"       Special populations:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Pediatrics: Intranasal corticosteroids may cause a reduction in growth velocity in pediatric patients (~1 centimeter per year [range 0.3-1.8 cm per year] and related to dose and duration of exposure). To minimize the systemic effects, each patient should be titrated to the lowest effective dose. Growth should be routinely monitored in pediatric patients.",
"    </p>",
"   </div>",
"   <div class=\"block cyt drugH1Div\" id=\"F13300165\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Metabolism/Transport Effects",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     <b>",
"      Substrate",
"     </b>",
"     of CYP3A4 (minor);",
"     <b>",
"      Note:",
"     </b>",
"     Assignment of Major/Minor substrate status based on clinically relevant drug interaction potential",
"    </p>",
"   </div>",
"   <div class=\"block dri drugH1Div\" id=\"F9606624\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Drug Interactions",
"    </span>",
"    <br/>",
"    <br/>",
"    <div class=\"lexi\" id=\"lexiInteractAddInfo\">",
"     (For additional information:",
"     <a class=\"dip\" href=\"./drug-interaction\" target=\"_blank\">",
"      Launch Lexi-Interact&trade; Drug Interactions Program",
"     </a>",
"     )",
"    </div>",
"    <div class=\"lexi\" id=\"lexiInteractImgB\">",
"     <img border=\"0\" height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"    </div>",
"    <div class=\"clear\">",
"    </div>",
"    <p style=\"text-indent:0em;display:inline\">",
"     There are no known significant interactions.",
"    </p>",
"   </div>",
"   <div class=\"block prf drugH1Div\" id=\"F9606565\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pregnancy Risk Factor",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     C (",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?16/42/17068\">",
"      show table",
"     </a>",
"     )",
"    </p>",
"   </div>",
"   <div class=\"block pri drugH1Div\" id=\"F9606566\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pregnancy Implications",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Triamcinolone was shown to be teratogenic in animal reproduction studies. Some studies have shown an association between first trimester corticosteroid use and oral clefts; adverse events in the fetus/neonate have been noted in case reports following large doses of systemic corticosteroids during pregnancy. Inhaled corticosteroids are recommended for the treatment of allergic rhinitis during pregnancy.",
"    </p>",
"   </div>",
"   <div class=\"block lac drugH1Div\" id=\"F9606568\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Lactation",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Excretion in breast milk unknown/use caution",
"    </p>",
"   </div>",
"   <div class=\"block brc drugH1Div\" id=\"F9606569\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Breast-Feeding Considerations",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Corticosteroids are excreted in human milk; information specific to triamcinolone has not been located. The use of inhaled corticosteroids is not considered a contraindication to breast-feeding",
"    </p>",
"   </div>",
"   <div class=\"block fee drugH1Div\" id=\"F9606845\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pricing: U.S. (Medi-Span&reg;)",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Aerosol solution",
"     </b>",
"     (Nasacort AQ Nasal)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     55 mcg/ACT (16.5 g): $136.31",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Inhalation",
"     </b>",
"     (Triamcinolone Acetonide Nasal)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     55 mcg/ACT (16.5 g): $122.53",
"    </p>",
"   </div>",
"   <div class=\"block pha drugH1Div\" id=\"F9606677\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Mechanism of Action",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Suppresses the immune system by reducing activity and volume of the lymphatic system",
"    </p>",
"   </div>",
"   <div class=\"block phk drugH1Div\" id=\"F9606679\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pharmacodynamics/Kinetics",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Absorption: Systemic absorption may occur following intranasal administration.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Half-life elimination: Biologic: 18-36 hours",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Excretion: Urine (~40%); feces (~60%)",
"    </p>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <div class=\"reference\">",
"      American Academy of Pediatrics Committee on Drugs: &ldquo;Transfer of Drugs and Other Chemicals Into Human Milk,&rdquo;",
"      <i>",
"       Pediatrics",
"      </i>",
"      , 2001, 108(3):776-89.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?5/32/5637/abstract-text/11533352/pubmed\" id=\"11533352\" target=\"_blank\">",
"        11533352",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Chow AW, Benninger MS, Brook I, et al, &ldquo;IDSA Clinical Practice Guideline for Acute Bacterial Rhinosinusitis in Children and Adults,&rdquo;",
"      <i>",
"       Clin Infect Dis",
"      </i>",
"      , 2012, 54(8):e72-112.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?5/32/5637/abstract-text/22438350/pubmed\" id=\"22438350\" target=\"_blank\">",
"        22438350",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      NAEPP Working Group Report on &ldquo;Managing Asthma During Pregnancy: Recommendations for Pharmacologic Treatment,&rdquo; National Institutes of Health, National Heart, Lung, and Blood Institute, NIH Publication No. 05-5236, March 2005. Available at",
"      <a href=\"file://www.nhlbi.nih.gov/health/prof/lung/asthma/astpreg/astpreg_full.pdf\" target=\"_blank\">",
"       file://www.nhlbi.nih.gov/health/prof/lung/asthma/astpreg/astpreg_full.pdf",
"      </a>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Pradat P, Robert-Gnansia E, Di Tanna GL, et al, &ldquo;First Trimester Exposure to Corticosteroids and Oral Clefts,&rdquo;",
"      <i>",
"       Birth Defects Res A Clin Mol Teratol",
"      </i>",
"      , 2003, 67(12):968-70.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?5/32/5637/abstract-text/14745915/pubmed\" id=\"14745915\" target=\"_blank\">",
"        14745915",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Reed, BR, &ldquo;Dermatologic Drugs, Pregnancy, and Lactation. A Conservative Guide,&rdquo;",
"      <i>",
"       Arch Dermatol",
"      </i>",
"      , 1997, 133(7):894-8.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?5/32/5637/abstract-text/9236528/pubmed\" id=\"9236528\" target=\"_blank\">",
"        9236528",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 9951 Version 32.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0504-118.195.65.248-66B715A8D5-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f5_32_5637=[""].join("\n");
var outline_f5_32_5637=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F9606519\">",
"      Brand Names: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F9606520\">",
"      Brand Names: Canada",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F9608610\">",
"      Pharmacologic Category",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F9606717\">",
"      Dosing: Adult",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F9606716\">",
"      Dosing: Pediatric",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F9606718\">",
"      Dosing: Geriatric",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F9606843\">",
"      Dosage Forms: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F9606563\">",
"      Generic Equivalent Available: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F9606775\">",
"      Administration",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F9606564\">",
"      Use",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F14225240\">",
"      Use - Unlabeled",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F9606497\">",
"      Medication Safety Issues",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F9606591\">",
"      Adverse Reactions Significant",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F9606570\">",
"      Contraindications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F9606571\">",
"      Warnings/Precautions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F13300165\">",
"      Metabolism/Transport Effects",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F9606624\">",
"      Drug Interactions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F9606565\">",
"      Pregnancy Risk Factor",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F9606566\">",
"      Pregnancy Implications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F9606568\">",
"      Lactation",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F9606569\">",
"      Breast-Feeding Considerations",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F9606845\">",
"      Pricing: U.S. (Medi-Span&reg;)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F9606677\">",
"      Mechanism of Action",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F9606679\">",
"      Pharmacodynamics/Kinetics",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"DRUG_GEN/9951\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"DRUG_GEN/9951|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?23/39/24183\" title=\"Lexicomp clinical abbreviations\">",
"      Lexicomp clinical abbreviations",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_patient\" href=\"UTD.htm?16/10/16548?source=related_link\">",
"      Triamcinolone (nasal): Patient drug information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_pediatric\" href=\"UTD.htm?15/56/16260?source=related_link\">",
"      Triamcinolone (nasal): Pediatric drug information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_general\" href=\"UTD.htm?7/55/8052?source=related_link\">",
"      Triamcinolone (ophthalmic): Drug information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_patient\" href=\"UTD.htm?19/31/19955?source=related_link\">",
"      Triamcinolone (ophthalmic): Patient drug information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_pediatric\" href=\"UTD.htm?16/36/16963?source=related_link\">",
"      Triamcinolone (ophthalmic): Pediatric drug information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_general\" href=\"UTD.htm?31/1/31768?source=related_link\">",
"      Triamcinolone (systemic): Drug information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_patient\" href=\"UTD.htm?5/49/5910?source=related_link\">",
"      Triamcinolone (systemic): Patient drug information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_pediatric\" href=\"UTD.htm?27/11/27831?source=related_link\">",
"      Triamcinolone (systemic): Pediatric drug information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_general\" href=\"UTD.htm?31/30/32229?source=related_link\">",
"      Triamcinolone (topical): Drug information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_patient\" href=\"UTD.htm?35/46/36580?source=related_link\">",
"      Triamcinolone (topical): Patient drug information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_pediatric\" href=\"UTD.htm?14/10/14500?source=related_link\">",
"      Triamcinolone (topical): Pediatric drug information",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f5_32_5638="Orlistat: Drug information";
var content_f5_32_5638=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"3\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"drugTitle\">",
"   Orlistat: Drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   (For additional information",
"   <a class=\"drug drug_patient\" href=\"UTD.htm?25/8/25732?source=see_link\">",
"    see \"Orlistat: Patient drug information\"",
"   </a>",
"   )",
"   <br/>",
"   For abbreviations and symbols that may be used in Lexicomp (",
"   <a class=\"graphic graphic_table\" href=\"UTD.htm?23/39/24183\">",
"    show table",
"   </a>",
"   )",
"   <div class=\"list ubnlist drugH1Div drugBrandNames\" id=\"F203918\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: U.S.",
"    </span>",
"    <ul>",
"     <li>",
"      Alli&reg; [OTC];",
"     </li>",
"     <li>",
"      Xenical&reg;",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"list cbnlist drugH1Div drugBrandNames\" id=\"F203919\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: Canada",
"    </span>",
"    <ul>",
"     <li>",
"      Xenical&reg;",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ex_sect_xr thclist drugH1Div drugBrandNames\" id=\"F203947\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pharmacologic Category",
"    </span>",
"    <ul>",
"     <li>",
"      Lipase Inhibitor",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"block doa drugH1Div\" id=\"F203922\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Adult",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     <b>",
"      Obesity:",
"     </b>",
"     Oral:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Xenical&reg;: 120 mg 3 times/day with each main meal containing fat (during or up to 1 hour after the meal); omit dose if meal is occasionally missed or contains no fat.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Alli&trade;: OTC labeling: 60 mg 3 times/day with each main meal containing fat",
"    </p>",
"   </div>",
"   <div class=\"block dop drugH1Div\" id=\"F203935\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Pediatric",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     <b>",
"      Obesity (Xenical&reg;):",
"     </b>",
"     Children &ge;12 years: Refer to adult dosing.",
"    </p>",
"   </div>",
"   <div class=\"block doe drugH1Div\" id=\"F203923\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Geriatric",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Refer to adult dosing.",
"    </p>",
"   </div>",
"   <div class=\"block foc drugH1Div\" id=\"F203901\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosage Forms: U.S.",
"    </span>",
"    <p style=\"text-indent:0em;text-align:justify;display:inline\">",
"     Excipient information presented when available (limited, particularly for generics); consult specific product labeling.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Capsule, oral:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Alli&reg;: 60 mg",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Xenical&reg;: 120 mg",
"    </p>",
"   </div>",
"   <div class=\"block geq drugH1Div\" id=\"F203888\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Generic Equivalent Available: U.S.",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     No",
"    </p>",
"   </div>",
"   <div class=\"block adm drugH1Div\" id=\"F7286032\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Administration",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Administer during or up to 1 hour after each main meal containing fat.",
"    </p>",
"   </div>",
"   <div class=\"block use drugH1Div\" id=\"F203902\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Use",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Management of obesity, including weight loss and weight management, when used in conjunction with a reduced-calorie and low-fat diet; reduce the risk of weight regain after prior weight loss; indicated for obese patients with an initial body mass index (BMI) &ge;30 kg/m",
"     <sup>",
"      2",
"     </sup>",
"     or &ge;27 kg/m",
"     <sup>",
"      2",
"     </sup>",
"     in the presence of other risk factors (eg, diabetes, dyslipidemia, hypertension)",
"    </p>",
"   </div>",
"   <div class=\"block mst drugH1Div\" id=\"F2702460\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Medication Safety Issues",
"    </span>",
"    <div class=\"collapsible\">",
"     <span class=\"collapsible-title\">",
"      Sound-alike/look-alike issues:",
"     </span>",
"     <div class=\"collapsible-wrap\">",
"      <p style=\"text-indent:-2em;margin-left:4em;\">",
"       Xenical&reg; may be confused with Xeloda&reg;",
"      </p>",
"     </div>",
"    </div>",
"   </div>",
"   <div class=\"block ars drugH1Div\" id=\"F203945\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Adverse Reactions Significant",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     <b>",
"      Note:",
"     </b>",
"     The frequency of most adverse reactions (especially gastrointestinal effects) decreases over time.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     &gt;10%:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Central nervous system: Headache (&le;31%)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Gastrointestinal: Oily spotting (4% to 27%), abdominal pain/discomfort (&le;26%), flatus with discharge (2% to 24%), fecal urgency (3% to 22%), fatty/oily stool (6% to 20%), oily evacuation (2% to 12%), defecation increased (3% to 11%)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Neuromuscular &amp; skeletal: Back pain (&le;14%)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Respiratory: Upper respiratory infection (26% to 38%)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Miscellaneous: Influenza (&le;40%)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     1% to 10%:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Cardiovascular: Pedal edema (&le;3%)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Central nervous system: Fatigue (3% to 7%), anxiety (3% to 5%), sleep disorder (&le;4%)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Dermatologic: Dry skin (&le;2%)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Endocrine &amp; metabolic: Menstrual irregularities (&le;10%)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Gastrointestinal: Nausea (4% to 8%), fecal incontinence (2% to 8%), infectious diarrhea (&le;5%), rectal pain/discomfort (3% to 5%), tooth disorder (3% to 4%), gingival disorder (2% to 4%)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Genitourinary: Urinary tract infection (6% to 8%), vaginitis (3% to 4%)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Neuromuscular &amp; skeletal: Myalgia (&le;4%)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Otic: Otitis (3% to 4%)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Respiratory: Lower respiratory infection (&le;8%)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     &lt;1% (Limited to important or life-threatening): Abdominal distension (in patients with diabetes), alkaline phosphatase increased, anaphylaxis, angioedema, bronchospasm, bullous eruption, cholelithiasis (may be caused by weight loss), coagulation parameters altered (concurrent use with warfarin), hepatic failure, hepatitis, hypersensitivity, hypoglycemia (in patients with diabetes), hypothyroidism (concurrent use with levothyroxine), kidney injury (acute), pancreatitis, pruritus, rash, transaminases increased, urinary oxalate levels increased, urticaria",
"    </p>",
"   </div>",
"   <div class=\"block coi drugH1Div\" id=\"F203906\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Contraindications",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Hypersensitivity to orlistat or any component of the formulation; chronic malabsorption syndrome or cholestasis; pregnancy",
"    </p>",
"   </div>",
"   <div class=\"block war drugH1Div\" id=\"F203892\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Warnings/Precautions",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      <i>",
"       Concerns related to adverse effects:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Cholelithiasis: In general, substantial weight loss may increase the risk of cholelithiasis.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Hepatotoxicity: Cases of severe liver injury (some fatal) with hepatocellular necrosis or acute hepatic failure have been reported (rare); liver transplantation has been required in some patients. Patients should be instructed to report any symptoms of hepatic dysfunction (eg, anorexia, pruritus, jaundice, dark urine, light colored stools, right upper quadrant pain); discontinue orlistat and obtain liver function test immediately if symptoms occur.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Increased urinary oxalate: Increased levels of urinary oxalate following treatment may occur in some patients; monitor renal function in patients at risk for renal failure; use with caution in patients with a history of hyperoxaluria or calcium oxalate nephrolithiasis.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      <i>",
"       Disease-related concerns:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Diabetes: Monitor patients with diabetes closely; dosage adjustments of antidiabetic medications may be necessary.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      <i>",
"       Concurrent drug therapy issues:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Cyclosporine: Orlistat may decrease cyclosporine plasma concentrations; administer cyclosporine &ge;3 hours before or after orlistat and monitor frequently.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      <i>",
"       Special populations:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Pediatrics: When used in adolescents, weight related to growth is accounted for in BMI, therefore, reduction in BMI is a better indicator of weight loss.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      <i>",
"       Other warnings/precautions:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Appropriate use: Prior to use other causes for obesity (eg, hypothyroidism) should be ruled out.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Dietary guidelines: Patients should be advised to adhere to dietary guidelines; if taken with a diet high in fat (&gt;30% total daily calories from fat), gastrointestinal adverse events may increase. Distribute daily fat intake over 3 main meals. If taken with any 1 meal very high in fat, the possibility of gastrointestinal effects increases. Counsel patients to take a multivitamin supplement that contains fat-soluble vitamins &ge;2 hours before or after orlistat administration to ensure adequate nutrition; orlistat has been shown to reduce the absorption of some fat-soluble vitamins and beta-carotene.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Potential for misuse: The potential exists for misuse in inappropriate patient populations (eg, patients with anorexia nervosa or bulimia) similar to any weight loss agent.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Self-medication (OTC use): Prior to use, patients should contact their healthcare provider if they have ever had kidney stones, gall bladder disease, or pancreatitis. Patients taking medications for diabetes or thyroid disease, anticoagulants, or other weight-loss products should consult their healthcare provider or pharmacist. Patients who have had an organ transplant should not use orlistat. If severe and/or continuous abdominal pain, itching, yellowing of the eyes or skin, dark urine, or loss of appetite occurs, use should be discontinued and healthcare provider consulted.",
"    </p>",
"   </div>",
"   <div class=\"block cyt drugH1Div\" id=\"F13299795\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Metabolism/Transport Effects",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     None known.",
"    </p>",
"   </div>",
"   <div class=\"block dri drugH1Div\" id=\"F203897\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Drug Interactions",
"    </span>",
"    <br/>",
"    <br/>",
"    <div class=\"lexi\" id=\"lexiInteractAddInfo\">",
"     (For additional information:",
"     <a class=\"dip\" href=\"./drug-interaction\" target=\"_blank\">",
"      Launch Lexi-Interact&trade; Drug Interactions Program",
"     </a>",
"     )",
"    </div>",
"    <div class=\"lexi\" id=\"lexiInteractImgB\">",
"     <img border=\"0\" height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"    </div>",
"    <div class=\"clear\">",
"    </div>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Amiodarone: Orlistat may decrease the absorption of Amiodarone.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     CycloSPORINE (Systemic): Orlistat may decrease the serum concentration of CycloSPORINE (Systemic).  Management: Administer orlistat at least 3 hours before or after oral cyclosporine.  Monitor for decreased serum concentrations of oral cyclosporine, even with the recommended dose separation.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Levothyroxine: Orlistat may decrease the serum concentration of Levothyroxine.  Management: Separate administration of oral levothyroxine and orlistat  by a least 4 hours. Monitor patients closely for signs and symptoms of hypothyroidism.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Multivitamins/Minerals (with ADEK, Folate, Iron): Orlistat may decrease the serum concentration of Multivitamins/Minerals (with ADEK, Folate, Iron). Specifically, orlistat may impair the absorption of fat-soluble vitamins.  Management: Administer oral fat soluble vitamins (such as vitamins A, D, E, and/or K that are contained in many multivitamin products) at least 2 hours before or after the administration of orlistat.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Paricalcitol: Orlistat may decrease the serum concentration of Paricalcitol.  Management: Monitor clinical response to paricalcitol closely when used with orlistat.  When this combination must be used, consider administering paricalcitol at least 2 hours before or after the administration of orlistat.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Propafenone: Orlistat may decrease the serum concentration of Propafenone.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Vitamin D Analogs: Orlistat may decrease the serum concentration of Vitamin D Analogs. More specifically, orlistat may impair absorption of Vitamin D Analogs.  Management: Monitor clinical response (including serum calcium) to oral vitamin D analogs closely if used with orlistat.  If this combination must be used, consider giving the vitamin D analog at least 2 hrs before or after orlistat.",
"     <b>",
"      Exceptions:",
"     </b>",
"     Calcipotriene.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Vitamins (Fat Soluble): Orlistat may decrease the serum concentration of Vitamins (Fat Soluble).  Management: Administer oral fat soluble vitamins at least 2 hours before or after the administration of orlistat.  Similar precautions do not apply to parenterally administered fat soluble vitamins.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Warfarin: Orlistat may enhance the anticoagulant effect of Warfarin.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"   </div>",
"   <div class=\"block foi drugH1Div\" id=\"F203915\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Ethanol/Nutrition/Herb Interactions",
"    </span>",
"    <p style=\"text-indent:0em;text-align:justify;display:inline\">",
"     Fat-soluble vitamins: Absorption of vitamins A, D, E, and K may be decreased by orlistat. A multivitamin containing the fat-soluble vitamins (A, D, E, and K) should be administered once daily at least 2 hours before or after orlistat.",
"    </p>",
"   </div>",
"   <div class=\"block prf drugH1Div\" id=\"F203898\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pregnancy Risk Factor",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     X (",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?16/42/17068\">",
"      show table",
"     </a>",
"     )",
"    </p>",
"   </div>",
"   <div class=\"block pri drugH1Div\" id=\"F203909\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pregnancy Implications",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Adverse events were not observed in animal reproduction studies. Although orlistat is minimally absorbed, weight-loss therapy is not recommended for pregnant women. Obese and overweight women should be encouraged to participate in weight reduction programs prior to attempting pregnancy; weight gain during pregnancy should be determined by their prepregnancy BMI and current guidelines (ADA, 2009; IOM, 2009). Use of orlistat is contraindicated in pregnant women.",
"    </p>",
"   </div>",
"   <div class=\"block lac drugH1Div\" id=\"F203925\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Lactation",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Excretion in breast milk unknown/use caution",
"    </p>",
"   </div>",
"   <div class=\"block brc drugH1Div\" id=\"F13761462\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Breast-Feeding Considerations",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Weight-loss therapy is generally not recommended for lactating women. Weight-loss programs which include physical activity and nutrition components should be discussed at the 6-week postpartum visit (ADA, 2009; IOM, 2009).",
"    </p>",
"   </div>",
"   <div class=\"block dic drugH1Div\" id=\"F203910\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dietary Considerations",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Multivitamin supplements that contain fat-soluble vitamins should be taken once daily at least 2 hours before or after the administration of orlistat (ie, bedtime). Gastrointestinal effects of orlistat may increase if taken with any one meal very high in fat. Distribute daily intake of  carbohydrates, fat (~30% of daily calories), and protein over three main meals.",
"    </p>",
"   </div>",
"   <div class=\"block fee drugH1Div\" id=\"F203908\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pricing: U.S. (Medi-Span&reg;)",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Capsules",
"     </b>",
"     (Alli Oral)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     60 mg (90): $51.52",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Capsules",
"     </b>",
"     (Xenical Oral)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     120 mg (90): $517.25",
"    </p>",
"   </div>",
"   <div class=\"block mop drugH1Div\" id=\"F7286034\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Monitoring Parameters",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     BMI; diet (calorie and fat intake); serum glucose in patients with diabetes; thyroid function in patient with thyroid disease; liver function tests in patients exhibiting symptoms of hepatic dysfunction",
"    </p>",
"   </div>",
"   <div class=\"list fbnlist drugH1Div drugBrandNames\" id=\"F203911\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     International Brand Names",
"    </span>",
"    <ul>",
"     <li>",
"      Alli (HK, NZ, TW);",
"     </li>",
"     <li>",
"      Aslene (MY);",
"     </li>",
"     <li>",
"      Cuvarlix (MY);",
"     </li>",
"     <li>",
"      Digrasil (CO, PE);",
"     </li>",
"     <li>",
"      Lakshmi (KP);",
"     </li>",
"     <li>",
"      Lesofat (PH);",
"     </li>",
"     <li>",
"      Lipidown (KP);",
"     </li>",
"     <li>",
"      Obestal (PH);",
"     </li>",
"     <li>",
"      Oliet (KP);",
"     </li>",
"     <li>",
"      Redustat (DO, GT, PA, SV);",
"     </li>",
"     <li>",
"      Sidelg (CO, CR, DO, HN, NI, PA, SV);",
"     </li>",
"     <li>",
"      Verte (PE);",
"     </li>",
"     <li>",
"      Xenical (AR, AT, AU, BB, BE, BF, BG, BJ, BM, BO, BR, BS, BZ, CH, CI, CL, CN, CO, CZ, DE, DK, EC, EE, ES, ET, FI, FR, GB, GH, GM, GN, GR, GY, HK, HU, ID, IE, IL, IT, JM, KE, LR, MA, ML, MR, MT, MU, MW, MX, NE, NG, NL, NO, NZ, PE, PH, PK, PL, PR, PT, PY, RU, SC, SD, SE, SG, SK, SL, SN, SR, TH, TN, TR, TT, TW, TZ, UG, UY, VE, ZA, ZM, ZW);",
"     </li>",
"     <li>",
"      Zero-X (KP)",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"block pha drugH1Div\" id=\"F203891\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Mechanism of Action",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     A reversible inhibitor of gastric and pancreatic lipases, thus inhibiting absorption of dietary fats by 30% (at doses of 120 mg 3 times/day).",
"    </p>",
"   </div>",
"   <div class=\"block phk drugH1Div\" id=\"F203905\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pharmacodynamics/Kinetics",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Onset of action: 24-48 hours",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Duration: 48-72 hours",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Absorption: Minimal",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Protein binding: &gt;99% (lipoproteins and albumin)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Metabolism: Metabolized within the gastrointestinal wall; forms inactive metabolites",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Half-life elimination: 1-2 hours",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Time to peak, serum: ~8 hours",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Excretion: Feces (~97%, 83% as unchanged drug); urine (&lt;2%)",
"    </p>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <div class=\"reference\">",
"      American Dietetic Association; American Society of Nutrition, Siega-Riz AM, et al, \"Position of the American Dietetic Association and American Society for Nutrition: Obesity, Reproduction, and Pregnancy Outcomes,\"",
"      <i>",
"       J Am Diet Assoc",
"      </i>",
"      , 2009, 109(5):918-27.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?5/32/5638/abstract-text/19412993/pubmed\" id=\"19412993\" target=\"_blank\">",
"        19412993",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      August GP, Caprio S, Fennoy I, et al, &ldquo;Prevention and Treatment of Pediatric Obesity: An Endocrine Society Clinical Practice Guideline Based on Expert Opinion,&rdquo;",
"      <i>",
"       J Clin Endocrinol Metab",
"      </i>",
"      , 2008, 93(12):4576-99.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?5/32/5638/abstract-text/18782869/pubmed\" id=\"18782869\" target=\"_blank\">",
"        18782869",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Davidson MH, Hauptman J, DiGirolamo M, et al, &ldquo;Weight Control and Risk Factor Reduction in Obese Subjects Treated for 2 Years With Orlistat: A Randomized Controlled Trial,&rdquo;",
"      <i>",
"       JAMA",
"      </i>",
"      , 1999, 281(3):235-42.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?5/32/5638/abstract-text/9918478/pubmed\" id=\"9918478\" target=\"_blank\">",
"        9918478",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Heymsfield SB, Segal KR, Hauptman J, et al, &ldquo;Effects of Weight Loss With Orlistat on Glucose Tolerance and Progression to Type 2 Diabetes in Obese Adults,&rdquo;",
"      <i>",
"       Arch Intern Med",
"      </i>",
"      , 2000, 160(9):1321-6.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?5/32/5638/abstract-text/10809036/pubmed\" id=\"10809036\" target=\"_blank\">",
"        10809036",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Hollander PA, Elbein SC, Hirsch IB, et al, &ldquo;Role of Orlistat in the Treatment of Obese Patients With Type 2 Diabetes. A 1-year Randomized Double-Blind Study,&rdquo;",
"      <i>",
"       Diabetes Care",
"      </i>",
"      , 1998, 21(8):1288-94.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?5/32/5638/abstract-text/9702435/pubmed\" id=\"9702435\" target=\"_blank\">",
"        9702435",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      IOM (Institute of Medicine) and NRC (National Research Council), \"Weight Gain During Pregnancy: Reexamining the Guidelines,\" Washington, DC: The National Academies Press, 2009. Available at",
"      <a href=\"file://www.nap.edu\" target=\"_blank\">",
"       file://www.nap.edu",
"      </a>",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?5/32/5638/abstract-text/20669500/pubmed\" id=\"20669500\" target=\"_blank\">",
"        20669500",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      McTigue KM, Harris R, Hemphill B, et al, &ldquo;Screening and Interventions for Obesity in Adults: Summary of the Evidence for the U.S. Preventive Services Task Force,&rdquo;",
"      <i>",
"       Ann Intern Med",
"      </i>",
"      , 2003, 139(11):933-49.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?5/32/5638/abstract-text/14644897/pubmed\" id=\"14644897\" target=\"_blank\">",
"        14644897",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      National Heart, Lung, and Blood Institute Obesity Education Initiative, &ldquo;Clinical Guidelines on the Identification, Evaluation, and Treatment of Overweight and Obesity in Adults. The Evidence Report,&rdquo;",
"      <i>",
"       NIH Publication",
"      </i>",
"      No. 98-4083. Bethesda, MD: U.S. Department of Health and Human Services, Public Health Service, National Institutes of Health, National Heart, Lung, and Blood Institute, 1998.",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Snow V, Barry P, Fitterman N, et al, &ldquo;Pharmacologic and Surgical Management of Obesity in Primary Care: A Clinical Practice Guideline From the American College of Physicians,&rdquo;",
"      <i>",
"       Ann Intern Med",
"      </i>",
"      , 2005, 142(7):525-31.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?5/32/5638/abstract-text/15809464/pubmed\" id=\"15809464\" target=\"_blank\">",
"        15809464",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Torgenson JS, Pauptman J, Boldrin MN, et al, &ldquo;XENical in the Prevention of Diabetes in Obese Subjects (XENDOS) Study: A Randomized Study of Orlistat as an Adjunct to Lifestyle Changes for the Prevention of Type 2 Diabetes in Obese Patients,&rdquo;",
"      <i>",
"       Diabetes Care",
"      </i>",
"      , 2004, 27(1):155-61.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?5/32/5638/abstract-text/14693982/pubmed\" id=\"14693982\" target=\"_blank\">",
"        14693982",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Weir MA, Beyea MM, Gomes T, et al, \"Orlistat and Acute Kidney Injury: An Analysis of 953 Patients,\"",
"      <i>",
"       Arch Intern Med",
"      </i>",
"      , 2011, 171(7):703-4.",
"     </div>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 10179 Version 35.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0603-189.41.172.26-18D72DAC39-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f5_32_5638=[""].join("\n");
var outline_f5_32_5638=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F203918\">",
"      Brand Names: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F203919\">",
"      Brand Names: Canada",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F203947\">",
"      Pharmacologic Category",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F203922\">",
"      Dosing: Adult",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F203935\">",
"      Dosing: Pediatric",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F203923\">",
"      Dosing: Geriatric",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F203901\">",
"      Dosage Forms: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F203888\">",
"      Generic Equivalent Available: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F7286032\">",
"      Administration",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F203902\">",
"      Use",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F2702460\">",
"      Medication Safety Issues",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F203945\">",
"      Adverse Reactions Significant",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F203906\">",
"      Contraindications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F203892\">",
"      Warnings/Precautions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F13299795\">",
"      Metabolism/Transport Effects",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F203897\">",
"      Drug Interactions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F203915\">",
"      Ethanol/Nutrition/Herb Interactions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F203898\">",
"      Pregnancy Risk Factor",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F203909\">",
"      Pregnancy Implications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F203925\">",
"      Lactation",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F13761462\">",
"      Breast-Feeding Considerations",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F203910\">",
"      Dietary Considerations",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F203908\">",
"      Pricing: U.S. (Medi-Span&reg;)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F7286034\">",
"      Monitoring Parameters",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F203911\">",
"      International Brand Names",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F203891\">",
"      Mechanism of Action",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F203905\">",
"      Pharmacodynamics/Kinetics",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"DRUG_GEN/10179\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"DRUG_GEN/10179|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?23/39/24183\" title=\"Lexicomp clinical abbreviations\">",
"      Lexicomp clinical abbreviations",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_patient\" href=\"UTD.htm?25/8/25732?source=related_link\">",
"      Orlistat: Patient drug information",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f5_32_5639="Perioral rhytides";
var content_f5_32_5639=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=DERM%2F50746%7EDERM%2F62503&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=DERM%2F50746%7EDERM%2F62503&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 523px\">",
"   <div class=\"ttl\">",
"    Perioral rhytides",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 503px; height: 288px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Vertical wrinkles extending from the lip vermillion border are present. In this patient, the wrinkles are most evident on the lateral upper lip.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 522px\">",
"   <div class=\"ttl\">",
"    Example of botulinum toxin injection sites for perioral rhytides",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 502px; height: 288px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f5_32_5639=[""].join("\n");
var outline_f5_32_5639=null;
var title_f5_32_5640="Lung transplantation: Donor lung preservation";
var content_f5_32_5640=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Lung transplantation: Donor lung preservation",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?5/32/5640/contributors\">",
"     Authors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?5/32/5640/contributors\">",
"     Marcelo Cypel, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?5/32/5640/contributors\">",
"     Tom Waddell, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?5/32/5640/contributors\">",
"     Shaf Keshavjee, MD, MSc, FRCSC, FACS",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?5/32/5640/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?5/32/5640/contributors\">",
"     Elbert P Trulock, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?5/32/5640/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?5/32/5640/contributors\">",
"     Helen Hollingsworth, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?5/32/5640/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Apr 23, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Donor lung preservation refers to the process of maintaining and protecting a donor lung from the time of lung procurement up until implantation in the recipient. Many factors such as temperature, perfusion volume and pressure, oxygenation, and degree of inflation may impact the likelihood of lung injury during storage or at the time of reperfusion, and also the function of the lung after transplantation.",
"   </p>",
"   <p>",
"    Much of the experimental work in lung transplantation over the past decade has focused on optimizing methods of lung preservation to reduce the impact of ischemia-reperfusion injury on post-transplant lung function.",
"   </p>",
"   <p>",
"    The preservation of donor lungs for lung transplantation will be reviewed here. An overview of lung transplantation and discussions of donor evaluation and management, the lung transplantation procedure, early postoperative care, and primary graft dysfunction are provided separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?3/25/3480?source=see_link\">",
"     \"Lung transplantation: An overview\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?12/8/12425?source=see_link\">",
"     \"Lung transplantation: Deceased donor evaluation and management\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?37/50/38697?source=see_link\">",
"     \"Lung transplantation: Procedure and postoperative management\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?35/13/36057?source=see_link\">",
"     \"Primary lung graft dysfunction\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     DONOR LUNG PROCUREMENT",
"    </span>",
"    &nbsp;&mdash;&nbsp;The donor lung procurement operation is coordinated with cardiac procurement, such that the lungs and the heart may be used for separate recipients (",
"    <a class=\"graphic graphic_table graphicRef66453 \" href=\"UTD.htm?40/42/41643\">",
"     table 1",
"    </a>",
"    )&nbsp;[",
"    <a class=\"abstract\" href=\"UTD.htm?5/32/5640/abstract/1\">",
"     1",
"    </a>",
"    ]. Key goals include preventing in situ thrombosis and vasospasm and stabilizing the lung for cold storage.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h2\">",
"     Donation after brain death",
"    </span>",
"    &nbsp;&mdash;&nbsp;The procurement operation is usually performed through a median sternotomy [",
"    <a class=\"abstract\" href=\"UTD.htm?5/32/5640/abstract/1,2\">",
"     1,2",
"    </a>",
"    ]. In sequence, the pulmonary arteries are dissected free from the ascending aorta; the superior vena cava is dissected free up to the innominate bifurcation; the inferior vena cava transected; the left atrial appendage vented; and the aorta cross-clamped [",
"    <a class=\"abstract\" href=\"UTD.htm?5/32/5640/abstract/1,2\">",
"     1,2",
"    </a>",
"    ]. The azygos vein is ligated, but not divided. After the heart and lungs are exposed, the donor is anticoagulated with intravenous",
"    <a class=\"drug drug_general\" href=\"UTD.htm?39/34/40489?source=see_link\">",
"     heparin",
"    </a>",
"    (eg, 250 to 300 units per kg). A perfusion cannula is placed in the distal pulmonary artery at least 1.5 cm distal to the pulmonary valve and directed at the valve. The heart is perfused with cardioplegia solution retrograde from the ascending aorta and vented through the left atrium. In most protocols, a bolus of prostaglandin E1 (PGE1, alprostadil) 500 mcg is administered into the main pulmonary artery, followed by approximately 5.6 L of preservation solution (eg, low potassium",
"    <a class=\"drug drug_general\" href=\"UTD.htm?21/5/21588?source=see_link\">",
"     dextran",
"    </a>",
"    (Perfadex&reg;)), cooled to 4 to 8&ordm;C, is infused through the pulmonary artery while ventilation is continued. Both lungs should blanch equally with administration of the preservation solution. (See",
"    <a class=\"local\" href=\"#H5\">",
"     'Methods of preservation'",
"    </a>",
"    below.)",
"   </p>",
"   <p>",
"    Organ extraction follows topical cooling of the heart and lungs with an iced saline slush. The pulmonary veins are transected from the heart with a small cuff of left atrium; the superior vena cava and azygos vein are transected; and the main pulmonary artery is transected at the cannulation site. The heart is removed, and then the distal trachea and main bronchi are dissected free. The lungs are inflated to a peak pressure of 20 cmH20 with an FIO2 of 50 percent; the distal trachea is stapled and transected several centimeters above the carina; and the lungs are excised and packed in ice for transportation.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h2\">",
"     Donation after cardiac death",
"    </span>",
"    &nbsp;&mdash;&nbsp;A slightly different initial sequence is used for donation after cardiac death (also known as non-heart-beating donation or donation in circulatory determination of death) [",
"    <a class=\"abstract\" href=\"UTD.htm?5/32/5640/abstract/3,4\">",
"     3,4",
"    </a>",
"    ]. The first step is systemic heparinization, which is given either 30 minutes prior to withdrawal of clinical support, or at the time of declaration of death. After reintubation of the donor, a median sternotomy is rapidly performed; the pericardium is opened and the pulmonary artery cannulated and flushed, before any other dissection is performed. After flushing, the procedure follows that for donation after brain death, as described above.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h1\">",
"     METHODS OF PRESERVATION",
"    </span>",
"    &nbsp;&mdash;&nbsp;The optimal lung preservation solution, storage temperature, inflation volume, oxygen concentration, and pharmacologic additives needed to enhance lung graft success are not known. However, several lung preservation techniques have been developed to protect the procured donor lungs from the major insults (eg, ischemia, cold storage, and reperfusion) that may contribute to primary graft dysfunction and long-term mortality [",
"    <a class=\"abstract\" href=\"UTD.htm?5/32/5640/abstract/5,6\">",
"     5,6",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?35/13/36057?source=see_link\">",
"     \"Primary lung graft dysfunction\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Generally, preservation of the procured lungs is initiated with a hypothermic pulmonary artery flush of 50 to 60",
"    <span class=\"nowrap\">",
"     mL/kg",
"    </span>",
"    with a preservative solution, coupled with the topical administration of a cold solution [",
"    <a class=\"abstract\" href=\"UTD.htm?5/32/5640/abstract/7,8\">",
"     7,8",
"    </a>",
"    ]. Flushing uniformly cools the lung tissue and removes blood from the pulmonary vascular bed, thereby preventing thrombosis and endothelial injury from retained neutrophils [",
"    <a class=\"abstract\" href=\"UTD.htm?5/32/5640/abstract/9\">",
"     9",
"    </a>",
"    ]. Thereafter, the lungs are transported at 4 to 8&ordm;C in a partially inflated state. Specifics of this process are discussed below and are listed in the table (",
"    <a class=\"graphic graphic_table graphicRef79611 \" href=\"UTD.htm?8/7/8315\">",
"     table 2",
"    </a>",
"    ).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h2\">",
"     Preservation solutions",
"    </span>",
"    &nbsp;&mdash;&nbsp;Experimental work and clinical reports have favored the use of extracellular (colloid) solutions over intracellular (high potassium, low sodium crystalloid) type preservation solutions [",
"    <a class=\"abstract\" href=\"UTD.htm?5/32/5640/abstract/10-18\">",
"     10-18",
"    </a>",
"    ]. Examples of extracellular solutions include low-potassium",
"    <a class=\"drug drug_general\" href=\"UTD.htm?21/5/21588?source=see_link\">",
"     dextran",
"    </a>",
"    (LPD)-glucose solution (eg, Perfadex&reg; (Vitrolife, Sweden)) that was developed specifically for lung preservation, Cambridge solution, Celsior, and Papworth. Papworth contains Ringer&rsquo;s lactate,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?3/42/3752?source=see_link\">",
"     mannitol",
"    </a>",
"    , albumin, and donor blood. Euro-Collins and University of Wisconsin are intracellular solutions. Currently, Perfadex is the preservation solution used in the vast majority of lung transplant programs worldwide.",
"   </p>",
"   <p>",
"    The key components of LPD solutions are the",
"    <a class=\"drug drug_general\" href=\"UTD.htm?21/5/21588?source=see_link\">",
"     dextran",
"    </a>",
"    and low-potassium concentration. Dextran-40 in the LPD solution functions as an oncotic agent, tending to keep water in the intravascular compartment, and thereby decreasing interstitial edema formation. Dextran-40 also reduces the aggregation of erythrocytes and circulating thrombocytes, which may improve the microcirculation and reduce cellular activation [",
"    <a class=\"abstract\" href=\"UTD.htm?5/32/5640/abstract/19\">",
"     19",
"    </a>",
"    ]. The low-potassium concentration maintains normal pulmonary artery pressures during infusion. A further development is the dextran-glucose-based extracellular solution. The addition of glucose is designed to support aerobic metabolism and maintain cell integrity during prolonged ischemia. Perfadex is an LPD-glucose solution that is now available worldwide and used by most lung transplant centers. The addition of glucose to a lung preservation solution takes advantage of the unique aspect of lung physiology in transplantation; the inflated lung has the ability to supply oxygen to its parenchyma even during storage.",
"   </p>",
"   <p>",
"    Several studies have found better post-transplant outcomes (eg, frequency of primary graft dysfunction, duration of ventilator dependence, and 30 day mortality) with individual extracellular solutions [",
"    <a class=\"abstract\" href=\"UTD.htm?5/32/5640/abstract/12,13,15-17,20\">",
"     12,13,15-17,20",
"    </a>",
"    ]. As an example, a retrospective study examined outcomes among 310 consecutive lung transplant recipients whose donor lungs were preserved with Euro-Collins, Papworth, or Perfadex solution [",
"    <a class=\"abstract\" href=\"UTD.htm?5/32/5640/abstract/21\">",
"     21",
"    </a>",
"    ]. Lung preservation with Papworth solution was associated with increased mortality compared with the other solutions; preservation with Perfadex was associated with a decreased incidence of primary lung graft dysfunction at 48 hours. Another study retrospectively examined the likelihood of primary lung graft dysfunction among 157 consecutive patients whose donor lungs were preserved with one of three lung preservation solutions (Perfadex, Euro-Collins, and Papworth) [",
"    <a class=\"abstract\" href=\"UTD.htm?5/32/5640/abstract/20\">",
"     20",
"    </a>",
"    ]. Perfadex was superior in preventing moderate to severe grades of primary graft dysfunction, and a trend towards superiority in other early posttransplant outcomes was also noted [",
"    <a class=\"abstract\" href=\"UTD.htm?5/32/5640/abstract/22-24\">",
"     22-24",
"    </a>",
"    ]. In a separate retrospective study, LPD (4161 recipients) was compared to University of Wisconsin solution (294 recipients) [",
"    <a class=\"abstract\" href=\"UTD.htm?5/32/5640/abstract/18\">",
"     18",
"    </a>",
"    ]. LPD was associated with a lower mortality at one year among high risk recipients, but no overall mortality difference was noted between the groups.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h2\">",
"     Pharmacologic additives",
"    </span>",
"    &nbsp;&mdash;&nbsp;Two pharmacologic agents, prostaglandins and glucocorticoids, have been broadly used for lung preservation. These drugs have been given as pretreatment of the donor before flushing, as part of the flush perfusate itself, and as a treatment for the recipient during and after reperfusion. Other aspects of management of potential lung transplant donors are discussed in detail separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?12/8/12425?source=see_link\">",
"     \"Lung transplantation: Deceased donor evaluation and management\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h3\">",
"     Prostaglandins",
"    </span>",
"    &nbsp;&mdash;&nbsp;Prostaglandins E1 (PGE1, alprostadil) and I2 (PGI2, prostacyclin,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?36/53/37716?source=see_link\">",
"     iloprost",
"    </a>",
"    (a PGI2 analog)) were originally chosen for lung preservation because their vasodilator activity offset the cold-induced vasoconstriction of the preservation solution and allowed a more even distribution of perfusion [",
"    <a class=\"abstract\" href=\"UTD.htm?5/32/5640/abstract/25\">",
"     25",
"    </a>",
"    ]. Subsequent study has found that prostaglandins have additional properties, particularly down regulation of proinflammatory cytokine expression that are probably more important in ameliorating ischemia-reperfusion injury [",
"    <a class=\"abstract\" href=\"UTD.htm?5/32/5640/abstract/26-29\">",
"     26-29",
"    </a>",
"    ]. Many centers routinely inject PGE-1 into the pulmonary artery just before flushing with preservation solution, although scientific data in humans is lacking.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h3\">",
"     Methylprednisolone",
"    </span>",
"    &nbsp;&mdash;&nbsp;High-dose",
"    <a class=\"drug drug_general\" href=\"UTD.htm?30/25/31129?source=see_link\">",
"     methylprednisolone",
"    </a>",
"    has become an empirical adjunct to most clinical protocols because of its anti-inflammatory actions [",
"    <a class=\"abstract\" href=\"UTD.htm?5/32/5640/abstract/30-32\">",
"     30-32",
"    </a>",
"    ]. Methylprednisolone, 15",
"    <span class=\"nowrap\">",
"     mg/kg,",
"    </span>",
"    is typically administered intravenously to the donor before procurement and to the recipient immediately before reperfusion. The use of hormonal therapy in deceased donors is discussed in more detail separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?12/8/12425?source=see_link&amp;anchor=H21#H21\">",
"     \"Lung transplantation: Deceased donor evaluation and management\", section on 'Hormonal therapy'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h2\">",
"     Temperature of preservation solution",
"    </span>",
"    &nbsp;&mdash;&nbsp;While the optimal temperature has been debated, most centers use a flush temperature of 4 to 8 &ordm;C [",
"    <a class=\"abstract\" href=\"UTD.htm?5/32/5640/abstract/6\">",
"     6",
"    </a>",
"    ]. Hypothermia reduces metabolic activity such that cell viability can be maintained in the face of ischemia (5 percent of the metabolic rate at 37 &ordm;C). Cold temperature preservation thus continues to be an important component of lung preservation [",
"    <a class=\"abstract\" href=\"UTD.htm?5/32/5640/abstract/33,34\">",
"     33,34",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h2\">",
"     Anterograde and retrograde flush",
"    </span>",
"    &nbsp;&mdash;&nbsp;Anterograde flush refers to the administration of flush solution through the pulmonary artery with drainage from the pulmonary veins. Retrograde flush refers to the administration of the flush solution to each pulmonary vein, usually 250 mL to each, with drainage through the pulmonary artery. The combination of both procedures appears to achieve better lung function; most transplant centers combine an anterograde flush followed by a retrograde flush [",
"    <a class=\"abstract\" href=\"UTD.htm?5/32/5640/abstract/35\">",
"     35",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    In an experimental model, a retrograde flush improved lung preservation, compared with anterograde flush alone [",
"    <a class=\"abstract\" href=\"UTD.htm?5/32/5640/abstract/36\">",
"     36",
"    </a>",
"    ]. This effect was attributed to a more effective clearance of red cells within the capillaries and better distribution of the flush solution. It also provides the added advantage of removing any clot or emboli in the pulmonary arteries.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h2\">",
"     Volume of preservation solution",
"    </span>",
"    &nbsp;&mdash;&nbsp;Although scientific data are limited regarding the ideal volume of preservation solution, typically about 60",
"    <span class=\"nowrap\">",
"     mL/kg",
"    </span>",
"    of perfusate are infused after lung extraction, as this successfully clears the lungs of blood cells and uniformly cools the lungs [",
"    <a class=\"abstract\" href=\"UTD.htm?5/32/5640/abstract/6\">",
"     6",
"    </a>",
"    ]. Usually this takes 15 to 20 minutes to complete [",
"    <a class=\"abstract\" href=\"UTD.htm?5/32/5640/abstract/8\">",
"     8",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h2\">",
"     Pressure of preservation solution infusion",
"    </span>",
"    &nbsp;&mdash;&nbsp;Data are limited regarding the optimal pulmonary artery pressure for infusion of the preservation solution. The need for complete clearance of the vascular bed has to be balanced against the risk of injury to the low pressure pulmonary vasculature [",
"    <a class=\"abstract\" href=\"UTD.htm?5/32/5640/abstract/6\">",
"     6",
"    </a>",
"    ]. We typically use a perfusion pressure in the lower range (10 to 15 mmHg) and avoid exceeding a maximum perfusion pressure of 22 mmHg (30 cm H2O) [",
"    <a class=\"abstract\" href=\"UTD.htm?5/32/5640/abstract/37,38\">",
"     37,38",
"    </a>",
"    ]. Once the vascular bed has been flushed, perfusion is discontinued during storage.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h2\">",
"     Lung inflation",
"    </span>",
"    &nbsp;&mdash;&nbsp;Inflation of the lungs with an oxygen mixture during the ischemic period appears to protect the lung; however, scientific information regarding ideal oxygen concentration and inflation pressure is limited [",
"    <a class=\"abstract\" href=\"UTD.htm?5/32/5640/abstract/39,40\">",
"     39,40",
"    </a>",
"    ]. Based on studies in animal models, three primary mechanisms are thought to contribute to the protective effect of inflation with oxygenated air:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Efficient aerobic metabolism is maintained.",
"     </li>",
"     <li>",
"      Integrity of pulmonary surfactant is preserved.",
"     </li>",
"     <li>",
"      Epithelial fluid transport is improved.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Lung inflation is generally limited to 50 percent of the total lung capacity or to an airway pressure of 20 cmH20 to avoid overdistention [",
"    <a class=\"abstract\" href=\"UTD.htm?5/32/5640/abstract/39,40\">",
"     39,40",
"    </a>",
"    ]. Usually, an inspired oxygen tension (FiO2) ranging from 30 to 50 percent is used. Once the lungs have been inflated, the trachea is clamped for storage.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15\">",
"    <span class=\"h2\">",
"     Storage temperature",
"    </span>",
"    &nbsp;&mdash;&nbsp;The ideal temperature for donor lung storage remains unclear. Preservation at 4 to 8&ordm;C decreases cellular metabolic activity and preserves the cellular function, however cold storage may compound some aspects of ischemia-reperfusion injury [",
"    <a class=\"abstract\" href=\"UTD.htm?5/32/5640/abstract/5\">",
"     5",
"    </a>",
"    ]. Specifically in the lung, hypothermia may result in increased extravascular fluid and pulmonary vasoconstriction, contributing to diminished oxygen exchange and increased vascular resistance after reperfusion. Some experimental work has suggested that lungs preserved at 10&ordm;C instead of 4&ordm;C had superior lung function after transplantation [",
"    <a class=\"abstract\" href=\"UTD.htm?5/32/5640/abstract/41\">",
"     41",
"    </a>",
"    ]. However, the most common temperature for lung storage continues to be 4&ordm;C, as the logistics of transportation may prolong storage time and necessitate the margin of safety provided by the lower temperature.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16\">",
"    <span class=\"h2\">",
"     Ischemic time",
"    </span>",
"    &nbsp;&mdash;&nbsp;The optimal and acceptable ischemic times are not known, although the longer the ischemic time, the greater the risk of severe reperfusion injury. Ischemic times up to 8 hours are generally considered acceptable. The risks of primary graft dysfunction and 30 day mortality increase with more than 8 hours of ischemia; however, ischemic times of up to 10 to 12 hours have been successfully reported [",
"    <a class=\"abstract\" href=\"UTD.htm?5/32/5640/abstract/5,42-44\">",
"     5,42-44",
"    </a>",
"    ]. Therefore, the decision to accept lungs with longer ischemic times is made with the consideration of the constellation of other predictive risk factors in the lung donor (eg, age, clinical variables, smoking history, etc) and also consideration of the status or condition of the recipient.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17\">",
"    <span class=\"h1\">",
"     NEW APPROACHES TO ORGAN PRESERVATION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Maintaining organ viability during preservation is an important prerequisite for successful outcome after transplantation. A variety of different approaches to reducing lung injury during storage are under investigation. Some examples are as follows:",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H18\">",
"    <span class=\"h2\">",
"     Experimental pharmacologic agents",
"    </span>",
"    &nbsp;&mdash;&nbsp;Several pharmacologic and biologic agents have shown some benefit in experimental models of lung transplantation, but have not been validated in human studies [",
"    <a class=\"abstract\" href=\"UTD.htm?5/32/5640/abstract/26,27,30,31,45-52\">",
"     26,27,30,31,45-52",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Prostaglandin E2 (PGE2)",
"     </li>",
"     <li>",
"      Oxygen free radical scavengers, such as superoxide dismutase, catalase",
"     </li>",
"     <li>",
"      Glutathione,",
"      <a class=\"drug drug_general\" href=\"UTD.htm?24/40/25223?source=see_link\">",
"       allopurinol",
"      </a>",
"      , dimethylthiourea, and",
"      <a class=\"drug drug_general\" href=\"UTD.htm?22/10/22695?source=see_link\">",
"       deferoxamine",
"      </a>",
"     </li>",
"     <li>",
"      <a class=\"drug drug_general\" href=\"UTD.htm?9/18/9514?source=see_link\">",
"       Verapamil",
"      </a>",
"     </li>",
"     <li>",
"      Platelet-activating factor antagonists",
"     </li>",
"     <li>",
"      Complement inhibitors (sCR-1)",
"     </li>",
"     <li>",
"      <a class=\"drug drug_general\" href=\"UTD.htm?13/28/13765?source=see_link\">",
"       Pentoxifylline",
"      </a>",
"     </li>",
"     <li>",
"      Inhaled nitric oxide,",
"      <a class=\"drug drug_general\" href=\"UTD.htm?11/24/11656?source=see_link\">",
"       nitroglycerin",
"      </a>",
"      , and",
"      <a class=\"drug drug_general\" href=\"UTD.htm?20/51/21302?source=see_link\">",
"       nitroprusside",
"      </a>",
"     </li>",
"     <li>",
"      Phosphodiesterase-5 inhibitors (eg,",
"      <a class=\"drug drug_general\" href=\"UTD.htm?32/19/33080?source=see_link\">",
"       sildenafil",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      Exogenous surfactant",
"     </li>",
"     <li>",
"      Endothelin-1 (ET-1) receptor antagonists",
"     </li>",
"     <li>",
"      Adenosine A2a receptor agonists",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The use of these agents to prevent or treat primary graft dysfunction is discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?35/13/36057?source=see_link\">",
"     \"Primary lung graft dysfunction\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H19\">",
"    <span class=\"h2\">",
"     Normothermic perfusion",
"    </span>",
"    &nbsp;&mdash;&nbsp;The cold static preservation system described above was developed in an era with younger organ donors and good-quality organs. However, in order to increase the availability of donor organs, older and sometimes injured donor organs are being used. The use of suboptimal donor lungs and difficulties assessing lung function in donation after cardiac death have made it necessary to explore alternative preservation techniques [",
"    <a class=\"abstract\" href=\"UTD.htm?5/32/5640/abstract/53\">",
"     53",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Hypothermic preservation inhibits cellular metabolism and eliminates the possibility of substantial reparative processes occurring after donor organ injury. For this reason, normothermic (37&ordm;C) or near-normothermic (25 to 34&ordm;C) ex vivo perfusion is becoming popular as a preservation alternative in kidney and liver transplantation [",
"    <a class=\"abstract\" href=\"UTD.htm?5/32/5640/abstract/54-59\">",
"     54-59",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Attempts at using a ventilating and perfusing machine for lung preservation have failed in the past, largely due to the development of lung edema and increases in pulmonary vascular resistance [",
"    <a class=\"abstract\" href=\"UTD.htm?5/32/5640/abstract/60-62\">",
"     60-62",
"    </a>",
"    ]. However, investigators have used an animal model to develop a perfusion system that allows evaluation of lung function ex vivo [",
"    <a class=\"abstract\" href=\"UTD.htm?5/32/5640/abstract/63\">",
"     63",
"    </a>",
"    ]. A key part of ex vivo perfusion is the identification of a specific solution (Steen&reg; solution) that allows for ex vivo perfusion of lungs without development of pulmonary edema. In an animal model and a single human case, after a short period (60 to 90 minutes) of ex vivo evaluation, lungs were successfully transplanted [",
"    <a class=\"abstract\" href=\"UTD.htm?5/32/5640/abstract/64\">",
"     64",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    An acellular, ex vivo lung perfusion (EVLP) technique that can maintain donor lungs for at least 12 hours at body temperature without inducing injury has been tested in porcine and human lungs [",
"    <a class=\"abstract\" href=\"UTD.htm?5/32/5640/abstract/65,66\">",
"     65,66",
"    </a>",
"    ]. After prolonged EVLP, lung function after transplantation was excellent. Using this acellular perfusion technique also allowed evaluation of lung function ex vivo. However, another animal model of EVLP was less successful; six hours of EVLP resulted in impaired lung function, manifest by increased pulmonary vascular resistance (PVR) and increased airway pressures towards the end of the procedure [",
"    <a class=\"abstract\" href=\"UTD.htm?5/32/5640/abstract/67\">",
"     67",
"    </a>",
"    ]. A clinical trial is underway using normothermic ex vivo lung perfusion as a method to reassess and optimize donor lungs that are initially unsuitable for transplantation.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H20\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Donor lung preservation refers to the process of maintaining a donor lung from the time of procurement until reperfusion in a way that will optimize post transplantation function. (See",
"      <a class=\"local\" href=\"#H1\">",
"       'Introduction'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Just prior to procurement, the donor is anticoagulated with",
"      <a class=\"drug drug_general\" href=\"UTD.htm?39/34/40489?source=see_link\">",
"       heparin",
"      </a>",
"      , and in most protocols, a bolus of alprostadil (PGE1) or",
"      <a class=\"drug drug_general\" href=\"UTD.htm?0/22/359?source=see_link\">",
"       epoprostenol",
"      </a>",
"      (prostacyclin) is administered into the pulmonary artery. (See",
"      <a class=\"local\" href=\"#H2\">",
"       'Donor lung procurement'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      During procurement, lungs are flushed with preservation solution at a temperature of 4 to 8&ordm;C and stored in ice at 4 to 8&ordm;C to reduce metabolic activity. An infusion of 60",
"      <span class=\"nowrap\">",
"       mL/kg",
"      </span>",
"      of perfusate solution at a pressure of 10 to 15 mmHg is usually sufficient to clear the lungs of blood cells and cool the lungs uniformly. (See",
"      <a class=\"local\" href=\"#H5\">",
"       'Methods of preservation'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Either prostaglandin E1 or I2 is usually added to flush solutions to reduce the production of inflammatory cytokines and offset cold-induced vasoconstriction. (See",
"      <a class=\"local\" href=\"#H8\">",
"       'Prostaglandins'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      To avoid overdistension, lung inflation is generally limited to 50 percent of the total lung capacity or to an airway pressure of 20 cmH20. An FiO2 between 30 and 50 percent is usual. (See",
"      <a class=\"local\" href=\"#H14\">",
"       'Lung inflation'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Ischemic times of up to 8 hours between procurement and re-implantation are generally considered acceptable; mortality risk increases with more than 8 hours of ischemia. However, successful outcomes have been reported with ischemic times up to 12 hours. (See",
"      <a class=\"local\" href=\"#H16\">",
"       'Ischemic time'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/32/5640/abstract/1\">",
"      Puri V, Patterson GA. Adult lung transplantation: technical considerations. Semin Thorac Cardiovasc Surg 2008; 20:152.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/32/5640/abstract/2\">",
"      Pasque MK. Standardizing thoracic organ procurement for transplantation. J Thorac Cardiovasc Surg 2010; 139:13.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/32/5640/abstract/3\">",
"      Daemen JW, Kootstra G, Wijnen RM, et al. Nonheart-beating donors: the Maastricht experience. Clin Transpl 1994; :303.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/32/5640/abstract/4\">",
"      Bernat JL, Capron AM, Bleck TP, et al. The circulatory-respiratory determination of death in organ donation. Crit Care Med 2010; 38:963.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/32/5640/abstract/5\">",
"      de Perrot M, Liu M, Waddell TK, Keshavjee S. Ischemia-reperfusion-induced lung injury. Am J Respir Crit Care Med 2003; 167:490.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/32/5640/abstract/6\">",
"      de Perrot M, Bonser RS, Dark J, et al. Report of the ISHLT Working Group on Primary Lung Graft Dysfunction part III: donor-related risk factors and markers. J Heart Lung Transplant 2005; 24:1460.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/32/5640/abstract/7\">",
"      Hopkinson DN, Bhabra MS, Hooper TL. Pulmonary graft preservation: a worldwide survey of current clinical practice. J Heart Lung Transplant 1998; 17:525.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/32/5640/abstract/8\">",
"      Fischer S, Matte-Martyn A, De Perrot M, et al. Low-potassium dextran preservation solution improves lung function after human lung transplantation. J Thorac Cardiovasc Surg 2001; 121:594.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/32/5640/abstract/9\">",
"      Veith FJ, Sinha SB, Graves JS, et al. Ischemic tolerance of the lung. The effect of ventilation and inflation. J Thorac Cardiovasc Surg 1971; 61:804.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/32/5640/abstract/10\">",
"      Steen S, Sj&ouml;berg T, Massa G, et al. Safe pulmonary preservation for 12 hours with low-potassium-dextran solution. Ann Thorac Surg 1993; 55:434.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/32/5640/abstract/11\">",
"      Keshavjee SH, Yamazaki F, Cardoso PF, et al. A method for safe twelve-hour pulmonary preservation. J Thorac Cardiovasc Surg 1989; 98:529.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/32/5640/abstract/12\">",
"      Str&uuml;ber M, Wilhelmi M, Harringer W, et al. Flush perfusion with low potassium dextran solution improves early graft function in clinical lung transplantation. Eur J Cardiothorac Surg 2001; 19:190.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/32/5640/abstract/13\">",
"      M&uuml;ller C, F&uuml;rst H, Reichenspurner H, et al. Lung procurement by low-potassium dextran and the effect on preservation injury. Munich Lung Transplant Group. Transplantation 1999; 68:1139.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/32/5640/abstract/14\">",
"      Aziz TM, Pillay TM, Corris PA, et al. Perfadex for clinical lung procurement: is it an advance? Ann Thorac Surg 2003; 75:990.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/32/5640/abstract/15\">",
"      Rega, F, Verleden, G, Vanhaecke, J, et al. Switch from Euro-Collins to Perfadex for pulmonary graft preservation resulted in superior outcome in transplant recipients. J Heart Lung Transplant 2003; 22 Suppl 1:S111.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/32/5640/abstract/16\">",
"      Rabanal JM, Iba&ntilde;ez AM, Mons R, et al. Influence of preservation solution on early lung function (Euro-Collins vs Perfadex). Transplant Proc 2003; 35:1938.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/32/5640/abstract/17\">",
"      Thabut G, Vinatier I, Brugi&egrave;re O, et al. Influence of preservation solution on early graft failure in clinical lung transplantation. Am J Respir Crit Care Med 2001; 164:1204.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/32/5640/abstract/18\">",
"      Arnaoutakis GJ, Allen JG, Merlo CA, et al. Low potassium dextran is superior to University of Wisconsin solution in high-risk lung transplant recipients. J Heart Lung Transplant 2010; 29:1380.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/32/5640/abstract/19\">",
"      Keshavjee SH, Yamazaki F, Yokomise H, et al. The role of dextran 40 and potassium in extended hypothermic lung preservation for transplantation. J Thorac Cardiovasc Surg 1992; 103:314.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/32/5640/abstract/20\">",
"      Oto T, Griffiths AP, Rosenfeldt F, et al. Early outcomes comparing Perfadex, Euro-Collins, and Papworth solutions in lung transplantation. Ann Thorac Surg 2006; 82:1842.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/32/5640/abstract/21\">",
"      Marasco SF, Bailey M, McGlade D, et al. Effect of donor preservation solution and survival in lung transplantation. J Heart Lung Transplant 2011; 30:414.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/32/5640/abstract/22\">",
"      M&uuml;hlfeld C, M&uuml;ller K, Pallesen LP, et al. Impact of preservation solution on the extent of blood-air barrier damage and edema formation in experimental lung transplantation. Anat Rec (Hoboken) 2007; 290:491.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/32/5640/abstract/23\">",
"      Mi&ntilde;ambres E, Gonz&aacute;lez-Castro A, Rabanal JM, et al. [Comparative study of two preservation solutions in the initial function after bilateral human lung transplantation]. Med Intensiva 2007; 31:1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/32/5640/abstract/24\">",
"      Okada Y, Kondo T. Impact of lung preservation solutions, Euro-Collins vs. low-potassium dextran, on early graft function: a review of five clinical studies. Ann Thorac Cardiovasc Surg 2006; 12:10.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/32/5640/abstract/25\">",
"      Puskas JD, Cardoso PF, Mayer E, et al. Equivalent eighteen-hour lung preservation with low-potassium dextran or Euro-Collins solution after prostaglandin E1 infusion. J Thorac Cardiovasc Surg 1992; 104:83.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/32/5640/abstract/26\">",
"      Novick RJ, Menkis AH, McKenzie FN. New trends in lung preservation: a collective review. J Heart Lung Transplant 1992; 11:377.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/32/5640/abstract/27\">",
"      Christie, NA, Waddell, TK. Lung preservation. Chest Surg Clin N Am 1993; 3:29.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/32/5640/abstract/28\">",
"      de Perrot M, Fischer S, Liu M, et al. Prostaglandin E1 protects lung transplants from ischemia-reperfusion injury: a shift from pro- to anti-inflammatory cytokines. Transplantation 2001; 72:1505.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/32/5640/abstract/29\">",
"      Gohrbandt B, Sommer SP, Fischer S, et al. Iloprost to improve surfactant function in porcine pulmonary grafts stored for twenty-four hours in low-potassium dextran solution. J Thorac Cardiovasc Surg 2005; 129:80.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/32/5640/abstract/30\">",
"      Kirk AJ, Colquhoun IW, Dark JH. Lung preservation: a review of current practice and future directions. Ann Thorac Surg 1993; 56:990.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/32/5640/abstract/31\">",
"      Novick RJ, Gehman KE, Ali IS, Lee J. Lung preservation: the importance of endothelial and alveolar type II cell integrity. Ann Thorac Surg 1996; 62:302.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/32/5640/abstract/32\">",
"      Venkateswaran RV, Patchell VB, Wilson IC, et al. Early donor management increases the retrieval rate of lungs for transplantation. Ann Thorac Surg 2008; 85:278.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/32/5640/abstract/33\">",
"      Pegg DE. Organ preservation. Surg Clin North Am 1986; 66:617.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/32/5640/abstract/34\">",
"      M&uuml;ller C, Hoffmann H, Bittmann I, et al. Hypothermic storage alone in lung preservation for transplantation: a metabolic, light microscopic, and functional analysis after 18 hours of preservation. Transplantation 1997; 63:625.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/32/5640/abstract/35\">",
"      Venuta F, Rendina EA, Bufi M, et al. Preimplantation retrograde pneumoplegia in clinical lung transplantation. J Thorac Cardiovasc Surg 1999; 118:107.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/32/5640/abstract/36\">",
"      Str&uuml;ber M, Hohlfeld JM, Kofidis T, et al. Surfactant function in lung transplantation after 24 hours of ischemia: advantage of retrograde flush perfusion for preservation. J Thorac Cardiovasc Surg 2002; 123:98.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/32/5640/abstract/37\">",
"      Tanaka H, Chiba Y, Sasaki M, et al. Relationship between flushing pressure and nitric oxide production in preserved lungs. Transplantation 1998; 65:460.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/32/5640/abstract/38\">",
"      Sasaki M, Muraoka R, Chiba Y, Hiramatu Y. Influence of pulmonary arterial pressure during flushing on lung preservation. Transplantation 1996; 61:22.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/32/5640/abstract/39\">",
"      DeCampos KN, Keshavjee S, Liu M, Slutsky AS. Optimal inflation volume for hypothermic preservation of rat lungs. J Heart Lung Transplant 1998; 17:599.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/32/5640/abstract/40\">",
"      Kayano K, Toda K, Naka Y, Pinsky DJ. Identification of optimal conditions for lung graft storage with Euro-Collins solution by use of a rat orthotopic lung transplant model. Circulation 1999; 100:II257.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/32/5640/abstract/41\">",
"      Wang LS, Yoshikawa K, Miyoshi S, et al. The effect of ischemic time and temperature on lung preservation in a simple ex vivo rabbit model used for functional assessment. J Thorac Cardiovasc Surg 1989; 98:333.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/32/5640/abstract/42\">",
"      Ganesh JS, Rogers CA, Banner NR, et al. Does the method of lung preservation influence outcome after transplantation? An analysis of 681 consecutive procedures. J Thorac Cardiovasc Surg 2007; 134:1313.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/32/5640/abstract/43\">",
"      Novick RJ, Bennett LE, Meyer DM, Hosenpud JD. Influence of graft ischemic time and donor age on survival after lung transplantation. J Heart Lung Transplant 1999; 18:425.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/32/5640/abstract/44\">",
"      Thabut G, Mal H, Cerrina J, et al. Graft ischemic time and outcome of lung transplantation: a multicenter analysis. Am J Respir Crit Care Med 2005; 171:786.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/32/5640/abstract/45\">",
"      Keshavjee S, Davis RD, Zamora MR, et al. A randomized, placebo-controlled trial of complement inhibition in ischemia-reperfusion injury after lung transplantation in human beings. J Thorac Cardiovasc Surg 2005; 129:423.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/32/5640/abstract/46\">",
"      Okabayashi K, Aoe M, DeMeester SR, et al. Pentoxifylline reduces lung allograft reperfusion injury. Ann Thorac Surg 1994; 58:50.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/32/5640/abstract/47\">",
"      Shaw MJ, Shennib H, Bousette N, et al. Effect of endothelin receptor antagonist on lung allograft apoptosis and NOSII expression. Ann Thorac Surg 2001; 72:386.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/32/5640/abstract/48\">",
"      Kawashima M, Nakamura T, Schneider S, et al. Iloprost ameliorates post-ischemic lung reperfusion injury and maintains an appropriate pulmonary ET-1 balance. J Heart Lung Transplant 2003; 22:794.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/32/5640/abstract/49\">",
"      Wittwer T, Franke UF, Fehrenbach A, et al. Donor pretreatment using the aerosolized prostacyclin analogue iloprost optimizes post-ischemic function of non-heart beating donor lungs. J Heart Lung Transplant 2005; 24:371.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/32/5640/abstract/50\">",
"      Reece TB, Laubach VE, Tribble CG, et al. Adenosine A2A receptor agonist improves cardiac dysfunction from pulmonary ischemia-reperfusion injury. Ann Thorac Surg 2005; 79:1189.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/32/5640/abstract/51\">",
"      Pizanis N, Milekhin V, Tsagakis K, et al. PDE-5 inhibitor donor intravenous preconditioning is superior to supplementation in standard preservation solution in experimental lung transplantation. Eur J Cardiothorac Surg 2007; 32:42.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/32/5640/abstract/52\">",
"      Sommer SP, Gohrbandt B, Fischer S, et al. Glutathione improves the function of porcine pulmonary grafts stored for twenty-four hours in low-potassium dextran solution. J Thorac Cardiovasc Surg 2005; 130:864.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/32/5640/abstract/53\">",
"      Maathuis MH, Leuvenink HG, Ploeg RJ. Perspectives in organ preservation. Transplantation 2007; 83:1289.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/32/5640/abstract/54\">",
"      Brasile L, Stubenitsky BM, Kootstra G. Solving the organ shortage: potential strategies and the likelihood of success. ASAIO J 2002; 48:211.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/32/5640/abstract/55\">",
"      Brasile L, Stubenitsky BM, Booster MH, et al. Overcoming severe renal ischemia: the role of ex vivo warm perfusion. Transplantation 2002; 73:897.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/32/5640/abstract/56\">",
"      Brasile L, Buelow R, Stubenitsky BM, Kootstra G. Induction of heme oxygenase-1 in kidneys during ex vivo warm perfusion. Transplantation 2003; 76:1145.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/32/5640/abstract/57\">",
"      Brasile L, Stubenitsky BM, Booster MH, et al. NOS: the underlying mechanism preserving vascular integrity and during ex vivo warm kidney perfusion. Am J Transplant 2003; 3:674.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/32/5640/abstract/58\">",
"      Brasile L, Stubenitsky BM, Haisch CE, et al. Repair of damaged organs in vitro. Am J Transplant 2005; 5:300.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/32/5640/abstract/59\">",
"      Imber CJ, St Peter SD, Lopez de Cenarruzabeitia I, et al. Advantages of normothermic perfusion over cold storage in liver preservation. Transplantation 2002; 73:701.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/32/5640/abstract/60\">",
"      Hardesty RL, Griffith BP. Autoperfusion of the heart and lungs for preservation during distant procurement. J Thorac Cardiovasc Surg 1987; 93:11.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/32/5640/abstract/61\">",
"      Brandes H, Albes JM, Conzelmann A, et al. Comparison of pulsatile and nonpulsatile perfusion of the lung in an extracorporeal large animal model. Eur Surg Res 2002; 34:321.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/32/5640/abstract/62\">",
"      Genco CM, Connolly RJ, Peterson MB, et al. Granulocyte sequestration and early failure in the autoperfused heart-lung preparation. Ann Thorac Surg 1992; 53:217.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/32/5640/abstract/63\">",
"      Steen S, Liao Q, Wierup PN, et al. Transplantation of lungs from non-heart-beating donors after functional assessment ex vivo. Ann Thorac Surg 2003; 76:244.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/32/5640/abstract/64\">",
"      Steen S, Sj&ouml;berg T, Pierre L, et al. Transplantation of lungs from a non-heart-beating donor. Lancet 2001; 357:825.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/32/5640/abstract/65\">",
"      Cypel M, Yeung JC, Hirayama S, et al. Technique for prolonged normothermic ex vivo lung perfusion. J Heart Lung Transplant 2008; 27:1319.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/32/5640/abstract/66\">",
"      Cypel M, Rubacha M, Yeung J, et al. Normothermic ex vivo perfusion prevents lung injury compared to extended cold preservation for transplantation. Am J Transplant 2009; 9:2262.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/32/5640/abstract/67\">",
"      Erasmus ME, Fernhout MH, Elstrodt JM, Rakhorst G. Normothermic ex vivo lung perfusion of non-heart-beating donor lungs in pigs: from pretransplant function analysis towards a 6-h machine preservation. Transpl Int 2006; 19:589.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 4652 Version 5.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0604-122.72.76.133-59BD6D52C2-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f5_32_5640=[""].join("\n");
var outline_f5_32_5640=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H20\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      DONOR LUNG PROCUREMENT",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      Donation after brain death",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      Donation after cardiac death",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      METHODS OF PRESERVATION",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      Preservation solutions",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      Pharmacologic additives",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      - Prostaglandins",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      - Methylprednisolone",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      Temperature of preservation solution",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      Anterograde and retrograde flush",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      Volume of preservation solution",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      Pressure of preservation solution infusion",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      Lung inflation",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H15\">",
"      Storage temperature",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H16\">",
"      Ischemic time",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H17\">",
"      NEW APPROACHES TO ORGAN PRESERVATION",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H18\">",
"      Experimental pharmacologic agents",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H19\">",
"      Normothermic perfusion",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H20\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"PULM/4652\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"PULM/4652|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?40/42/41643\" title=\"table 1\">",
"      Lung preservation procurement",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?8/7/8315\" title=\"table 2\">",
"      Lung preservation storage",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?3/25/3480?source=related_link\">",
"      Lung transplantation: An overview",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?12/8/12425?source=related_link\">",
"      Lung transplantation: Deceased donor evaluation and management",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?37/50/38697?source=related_link\">",
"      Lung transplantation: Procedure and postoperative management",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?35/13/36057?source=related_link\">",
"      Primary lung graft dysfunction",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f5_32_5641="Lactose intolerance";
var content_f5_32_5641=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"4\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Lactose intolerance",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?5/32/5641/contributors\">",
"     Authors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?5/32/5641/contributors\">",
"     Robert K Montgomery, PhD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?5/32/5641/contributors\">",
"     Richard J Grand, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?5/32/5641/contributors\">",
"     Hans A B&uuml;ller, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?5/32/5641/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?5/32/5641/contributors\">",
"     Lawrence S Friedman, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?5/32/5641/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?5/32/5641/contributors\">",
"     Shilpa Grover, MD, MPH",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?5/32/5641/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Mar 29, 2013.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Intolerance to lactose-containing foods (primarily dairy products) is a common problem [",
"    <a class=\"abstract\" href=\"UTD.htm?5/32/5641/abstract/1\">",
"     1",
"    </a>",
"    ]. In Europe and the United States, the prevalence is 7 to 20 percent in Caucasian adults (being lowest in those of northern European extraction) and is as high as 80 to 95 percent among Native Americans, 65 to 75 percent among Africans and African Americans, and 50 percent in Hispanics [",
"    <a class=\"abstract\" href=\"UTD.htm?5/32/5641/abstract/2\">",
"     2",
"    </a>",
"    ]. The prevalence exceeds 90 percent in some populations in eastern Asia.",
"   </p>",
"   <p>",
"    Clinical symptoms of lactose intolerance include diarrhea, abdominal pain, and flatulence after ingestion of milk or milk-containing products. These symptoms have been attributed to low intestinal",
"    <a class=\"drug drug_general\" href=\"UTD.htm?13/62/14306?source=see_link\">",
"     lactase",
"    </a>",
"    levels, which may be due to mucosal injury or, much more commonly, reduced genetic expression of the enzyme lactase-phlorizin hydrolase. However, as will be discussed below, intolerance to dairy products is not always a result of lactase deficiency.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     LACTOSE INTAKE",
"    </span>",
"    &nbsp;&mdash;&nbsp;Lactose intake varies with age. Among infants, carbohydrates (primarily lactose) account for 35 to 55 percent of daily calories ingested. Lactose intake falls as weaning foods are introduced and eventually approaches the level ingested by adults. On a typical western diet, the average adult ingests approximately 300 g of carbohydrates per day. Of these carbohydrates, approximately 52 percent are starch (mainly cereals and potatoes), 37 percent sucrose, 5 percent lactose (mainly in milk), and 3 percent as fructose (in fruit and honey). Glycogen, glucose, maltose, and cellulose are minor constituents of the diet.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h1\">",
"     LACTOSE DIGESTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Lactose digestion is the rate-limiting step in the overall process of its absorption. Lactose is hydrolyzed by intestinal",
"    <a class=\"drug drug_general\" href=\"UTD.htm?13/62/14306?source=see_link\">",
"     lactase",
"    </a>",
"    to glucose and galactose on the microvillus membrane of the intestinal adsorptive cells [",
"    <a class=\"abstract\" href=\"UTD.htm?5/32/5641/abstract/3\">",
"     3",
"    </a>",
"    ]. Uptake of these monosaccharides is accomplished by the sodium-dependent glucose carrier. Defects in this transporter result in severe diarrhea following carbohydrate intake [",
"    <a class=\"abstract\" href=\"UTD.htm?5/32/5641/abstract/4\">",
"     4",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h2\">",
"     Colonic salvage of nonabsorbed lactose",
"    </span>",
"    &nbsp;&mdash;&nbsp;Lactose that is not absorbed by the small bowel is passed rapidly into the colon. Up to 75 percent of lactose passes unabsorbed through the small intestine toward the cecum and colon in individuals with",
"    <a class=\"drug drug_general\" href=\"UTD.htm?13/62/14306?source=see_link\">",
"     lactase",
"    </a>",
"    deficiency [",
"    <a class=\"abstract\" href=\"UTD.htm?5/32/5641/abstract/5\">",
"     5",
"    </a>",
"    ]. In the colon, lactose is converted to short-chain fatty acids and hydrogen gas by the bacterial flora, producing acetate, butyrate, and propionate. The short-chain fatty acids are absorbed by the colonic mucosa, thereby salvaging the malabsorbed lactose for energy utilization. This is a mechanism by which the newborn colon salvages lactose and by which the adult who has low intestinal lactase activity can adapt to persistent lactose ingestion. The production of hydrogen by colonic bacteria serves as the basis for the lactose breath hydrogen test used to diagnose lactose maldigestion. (See",
"    <a class=\"local\" href=\"#H14\">",
"     'Lactose breath hydrogen test'",
"    </a>",
"    below.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h1\">",
"     ETIOLOGY OF LACTOSE MALABSORPTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;The causes of lactose malabsorption can be divided into primary",
"    <a class=\"drug drug_general\" href=\"UTD.htm?13/62/14306?source=see_link\">",
"     lactase",
"    </a>",
"    deficiency and lactase deficiency induced by underlying intestinal disease (",
"    <a class=\"graphic graphic_table graphicRef71595 \" href=\"UTD.htm?12/0/12299\">",
"     table 1",
"    </a>",
"    ). The term \"deficiency\" refers to levels compared with those (high) levels found in normal human infants at birth.",
"   </p>",
"   <p>",
"    There are three causes of primary lactose malabsorption:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Racial or ethnic lactose malabsorption",
"     </li>",
"     <li>",
"      Developmental",
"      <a class=\"drug drug_general\" href=\"UTD.htm?13/62/14306?source=see_link\">",
"       lactase",
"      </a>",
"      deficiency",
"     </li>",
"     <li>",
"      Congenital",
"      <a class=\"drug drug_general\" href=\"UTD.htm?13/62/14306?source=see_link\">",
"       lactase",
"      </a>",
"      deficiency",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h2\">",
"     Racial or ethnic lactose malabsorption",
"    </span>",
"    &nbsp;&mdash;&nbsp;Genetically regulated reduction of",
"    <a class=\"drug drug_general\" href=\"UTD.htm?13/62/14306?source=see_link\">",
"     lactase",
"    </a>",
"    activity determined by racial or ethnic factors is the underlying mechanism of lactose malabsorption in healthy individuals (also known as lactase nonpersistence). The majority of the world's populations develop low intestinal lactase levels during mid-childhood (approximately at age five years). This characteristic is most frequent in Asian and African populations; in contrast, the majority of Caucasians, particularly of northern European background, maintain elevated lactase activity into adulthood. Such persistent lactase activity has also been observed in multiple small populations throughout the world that historically domesticated cows or other milk providers and consumed milk products into adulthood. In some of these groups, there is evidence for convergent evolution of lactase persistence [",
"    <a class=\"abstract\" href=\"UTD.htm?5/32/5641/abstract/6\">",
"     6",
"    </a>",
"    ]. Genetic analysis has established that lactase persistence in adulthood is inherited as an autosomal dominant trait, but the molecular basis is incompletely understood [",
"    <a class=\"abstract\" href=\"UTD.htm?5/32/5641/abstract/2,7\">",
"     2,7",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Multiple single nucleotide polymorphisms (SNPs) in the DNA sequence of the coding region and the regulatory region of the",
"    <a class=\"drug drug_general\" href=\"UTD.htm?13/62/14306?source=see_link\">",
"     lactase",
"    </a>",
"    gene have been identified. Several haplotypes defined by such polymorphisms have been associated with persistence of elevated lactase expression [",
"    <a class=\"abstract\" href=\"UTD.htm?5/32/5641/abstract/8-10\">",
"     8-10",
"    </a>",
"    ]. In particular, presence of the T allele of the SNP located about 14kb upstream of the lactase gene has been strongly correlated with lactase persistence [",
"    <a class=\"abstract\" href=\"UTD.htm?5/32/5641/abstract/9\">",
"     9",
"    </a>",
"    ]. Several in vitro studies have suggested that this allele regulates levels of lactase mRNA and thus lactase persistence [",
"    <a class=\"abstract\" href=\"UTD.htm?5/32/5641/abstract/10-13\">",
"     10-13",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    However, studies in African milk drinking groups demonstrate the absence of the T allele, but the presence of additional polymorphisms in the same region of about 100 bp, which are associated with",
"    <a class=\"drug drug_general\" href=\"UTD.htm?13/62/14306?source=see_link\">",
"     lactase",
"    </a>",
"    persistence in different African groups [",
"    <a class=\"abstract\" href=\"UTD.htm?5/32/5641/abstract/6,14\">",
"     6,14",
"    </a>",
"    ]. At present, it remains unclear whether these polymorphisms have a causal role in lactase gene expression or provide markers for an as yet unidentified regulatory element. While assessment of the presence of the T allele at -14kb may provide a diagnostic test for lactase persistence or non-persistence in groups such as those of European origin, it will not be of value in African populations.",
"   </p>",
"   <p>",
"    Expression patterns in transgenic mice indicate that most of the regulatory elements required for cell-specific regulation of rat, as well as pig,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?13/62/14306?source=see_link\">",
"     lactase",
"    </a>",
"    are within the first two kb of 5' flanking sequence [",
"    <a class=\"abstract\" href=\"UTD.htm?5/32/5641/abstract/15,16\">",
"     15,16",
"    </a>",
"    ]. The transcription factors Cdx2, HNF-1a, and GATA are critical regulators of lactase expression [",
"    <a class=\"abstract\" href=\"UTD.htm?5/32/5641/abstract/17,18\">",
"     17,18",
"    </a>",
"    ]. All lactase genes examined so far, including the human gene, contain binding sites for these factors in the proximal promoter. In addition, the human genetic analysis indicates that the developmental decline may be regulated by more distant elements [",
"    <a class=\"abstract\" href=\"UTD.htm?5/32/5641/abstract/19\">",
"     19",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Molecular studies have generally found a positive correlation between",
"    <a class=\"drug drug_general\" href=\"UTD.htm?13/62/14306?source=see_link\">",
"     lactase",
"    </a>",
"    levels and lactase messenger ribonucleic acid (mRNA) expression, whether lactase activity is high or low [",
"    <a class=\"abstract\" href=\"UTD.htm?5/32/5641/abstract/20-22\">",
"     20-22",
"    </a>",
"    ]. This indicates that molecular regulation of this enzyme is at the level of gene transcription. In some subjects, however, there is a dissociation between lactase mRNA and lactase activity, suggesting that posttranscriptional factors also contribute to the decline in lactase biosynthesis, perhaps due to a partial block in transport of the enzyme from endoplasmic reticulum to the Golgi apparatus [",
"    <a class=\"abstract\" href=\"UTD.htm?5/32/5641/abstract/22,23\">",
"     22,23",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Immunohistochemical studies on small bowel biopsies have identified two patterns of immunoreactivity for",
"    <a class=\"drug drug_general\" href=\"UTD.htm?13/62/14306?source=see_link\">",
"     lactase",
"    </a>",
"    protein [",
"    <a class=\"abstract\" href=\"UTD.htm?5/32/5641/abstract/3\">",
"     3",
"    </a>",
"    ]. Adults with lactase persistence displayed strong intestinal brush border staining, indicating the presence of lactase. Some of the subjects with hypolactasia showed no staining for lactase, while others showed a mosaic pattern in which small patches of enterocytes stained strongly, but there was no staining in the surrounding areas.",
"   </p>",
"   <p>",
"    In the United States,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?13/62/14306?source=see_link\">",
"     lactase",
"    </a>",
"    activity is normal in all healthy children of any racial or ethnic group until approximately five years of age. Thus, lactose intolerance detected in younger children usually indicates an underlying mucosal lesion or bacterial overgrowth syndrome.",
"   </p>",
"   <p>",
"    The frequency of lactose maldigestion may increase with age and interact with racial predisposition [",
"    <a class=\"abstract\" href=\"UTD.htm?5/32/5641/abstract/24\">",
"     24",
"    </a>",
"    ]. In one report, for example, lactose malabsorption was more prevalent in a group of individuals &gt;74 years of age compared to the younger group (&lt;65) [",
"    <a class=\"abstract\" href=\"UTD.htm?5/32/5641/abstract/25\">",
"     25",
"    </a>",
"    ]. Although information of the individuals' ethnicity was not provided, the authors controlled for other potential confounders such as bacterial overgrowth and differences in intestinal transit.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h2\">",
"     Developmental lactase deficiency",
"    </span>",
"    &nbsp;&mdash;&nbsp;Developmental lactose malabsorption results from low",
"    <a class=\"drug drug_general\" href=\"UTD.htm?13/62/14306?source=see_link\">",
"     lactase",
"    </a>",
"    levels and is a consequence of prematurity. Lactase activity in the fetus increases late in gestation; thus, premature infants born at 28 to 32 weeks of gestation have reduced lactase activity [",
"    <a class=\"abstract\" href=\"UTD.htm?5/32/5641/abstract/26\">",
"     26",
"    </a>",
"    ]. If these infants are otherwise healthy, their colons can salvage the unabsorbed carbohydrate, preventing malnutrition and diarrhea.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h2\">",
"     Congenital lactase deficiency",
"    </span>",
"    &nbsp;&mdash;&nbsp;Congenital",
"    <a class=\"drug drug_general\" href=\"UTD.htm?13/62/14306?source=see_link\">",
"     lactase",
"    </a>",
"    deficiency (CLD) is a rare autosomal recessive disorder. The largest number of reported cases worldwide has been described in the Finnish population. The disorder is characterized by the absence of lactase activity in the small intestine, with normal histologic findings and normal levels of other disaccharidases. Genetic analysis has produced conflicting data. One study suggested that a gene located on the same chromosome, near, but distinct from, the lactase gene is responsible for CLD [",
"    <a class=\"abstract\" href=\"UTD.htm?5/32/5641/abstract/27\">",
"     27",
"    </a>",
"    ]. By contrast, a second study found that mutations exist within the coding region of the lactase gene [",
"    <a class=\"abstract\" href=\"UTD.htm?5/32/5641/abstract/28\">",
"     28",
"    </a>",
"    ]. Additional studies will be needed to reconcile these apparent discrepancies. Affected infants have diarrhea from birth, and have been reported to have hypercalcemia and nephrocalcinosis [",
"    <a class=\"abstract\" href=\"UTD.htm?5/32/5641/abstract/29\">",
"     29",
"    </a>",
"    ]. This disorder was usually fatal prior to the development of lactose-free infant formulas.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h2\">",
"     Secondary lactose malabsorption",
"    </span>",
"    &nbsp;&mdash;&nbsp;Lactose malabsorption can be induced by a variety of acquired disorders:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Bacterial overgrowth or stasis syndromes may be associated with increased fermentation of dietary lactose in the small bowel, often leading to symptoms of lactose intolerance. The diagnosis should be suspected from the clinical history and from a very early peak of breath hydrogen during lactose challenge.",
"     </li>",
"     <li>",
"      Lactose malabsorption can be seen with any form of mucosal injury of the gastrointestinal tract that causes villus flattening or damage to the intestinal epithelium (",
"      <a class=\"graphic graphic_table graphicRef71595 \" href=\"UTD.htm?12/0/12299\">",
"       table 1",
"      </a>",
"      ).",
"     </li>",
"     <li>",
"      At least one report suggested that patients with Crohn's disease of the small bowel have a higher prevalence of lactose malabsorption compared with patients with only colonic involvement [",
"      <a class=\"abstract\" href=\"UTD.htm?5/32/5641/abstract/30\">",
"       30",
"      </a>",
"      ]. However, a previous study found no difference in the prevalence of lactose malabsorption in children with Crohn's disease or ulcerative colitis [",
"      <a class=\"abstract\" href=\"UTD.htm?5/32/5641/abstract/31\">",
"       31",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <a class=\"drug drug_general\" href=\"UTD.htm?13/62/14306?source=see_link\">",
"     Lactase",
"    </a>",
"    is usually the first affected disaccharidase in these disorders, presumably because of its distal location on the villus. Treatment of the primary disorder can lead to restoration of lactase activity, which often lags behind the return of normal intestinal morphology. Lactose intolerance may persist for months after healing starts; this effect is unique to this enzyme and its biochemical basis is unexplained.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h1\">",
"     CLINICAL MANIFESTATIONS",
"    </span>",
"    &nbsp;&mdash;&nbsp;The term lactose intolerance is applied to the development of characteristic symptoms after the ingestion of lactose: abdominal pain, bloating, flatulence, diarrhea, and, particularly in adolescents, vomiting [",
"    <a class=\"abstract\" href=\"UTD.htm?5/32/5641/abstract/32-34\">",
"     32-34",
"    </a>",
"    ]. The abdominal pain may be crampy in nature and is often localized to the periumbilical area or lower quadrant. Borborygmi may be audible on physical examination and to the patient. The stools are usually bulky, frothy, and watery.",
"   </p>",
"   <p>",
"    There is a variability of symptoms among patients with lactose intolerance. Important factors include the osmolality and fat content of the food in which the sugar is ingested, the rate of gastric emptying, the sensitivity to intestinal distension produced by the osmotic load of unhydrolyzed lactose in the upper small bowel, the rate of intestinal transit, and the response of the colon to the carbohydrate load. The following general principles apply to the patient with lactose intolerance [",
"    <a class=\"abstract\" href=\"UTD.htm?5/32/5641/abstract/32\">",
"     32",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Meals with higher osmolality and fat content slow gastric emptying and reduce the severity of lactose-induced symptoms.",
"     </li>",
"     <li>",
"      The rate of intestinal transit is also influenced by individual motility patterns. People with more rapid movement of lactose to the cecum will generally be more symptomatic.",
"     </li>",
"     <li>",
"      Individuals have variable sensitivity to the abdominal distension produced when undigested lactose stimulates an influx of water into the lumen of the small intestine or gas production leads to distension of the colon [",
"      <a class=\"abstract\" href=\"UTD.htm?5/32/5641/abstract/35\">",
"       35",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    These subjective responses are difficult to quantify. As an example, patients with lactose intolerance who also have irritable bowel syndrome (IBS) may have increased pain after lactose ingestion. In one report of 427 healthy subjects, 15 percent of both lactose digesters and maldigesters met the symptom criteria for IBS. Although the prevalence of",
"    <a class=\"drug drug_general\" href=\"UTD.htm?13/62/14306?source=see_link\">",
"     lactase",
"    </a>",
"    deficiency was not higher in patients with IBS, patients who reported an intolerance of milk products had a higher likelihood of meeting the symptom criteria for IBS compared with patients who were tolerant to milk products (OR 4.6; 95% CI 2.1 to 10.1). A five-year prospective study evaluated a lactose restricted diet in patients with lactose malabsorption and irritable bowel syndrome. The study demonstrated improvement in both short- and long-term symptoms as well as a reduction in outpatient visits by 75 percent [",
"    <a class=\"abstract\" href=\"UTD.htm?5/32/5641/abstract/36\">",
"     36",
"    </a>",
"    ]. Other studies have confirmed the importance of subjective and perhaps psychological factors in the development of lactose-induced symptoms [",
"    <a class=\"abstract\" href=\"UTD.htm?5/32/5641/abstract/37\">",
"     37",
"    </a>",
"    ]. Given the similarity that may occur with regard to symptoms, a lactose breath hydrogen test or an empiric trial of a lactose free diet should be part of the evaluation of patients suspected of having irritable bowel syndrome [",
"    <a class=\"abstract\" href=\"UTD.htm?5/32/5641/abstract/36,38,39\">",
"     36,38,39",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Fecal flora can adapt to a chronic increase in dietary lactose, reducing the incidence and severity of symptoms following a lactose load. In a crossover study of this phenomenon, 20 patients with confirmed lactose maldigestion were randomized to lactose or dextrose supplementation for 10 days; the dose was gradually increased to 0.6 to 1.0",
"    <span class=\"nowrap\">",
"     g/kg",
"    </span>",
"    per day in three equal doses. There was no significant difference in symptoms during these periods [",
"    <a class=\"abstract\" href=\"UTD.htm?5/32/5641/abstract/40\">",
"     40",
"    </a>",
"    ]. Lactose challenge was performed after an overnight fast at the end of these periods. Lactose supplementation was associated with a 50 percent reduction in flatus passage and severity and a marked reduction in the hourly breath hydrogen concentration compared with dextrose supplementation.",
"   </p>",
"   <p>",
"    However, somewhat different results were noted in another crossover trial with a similar design [",
"    <a class=\"abstract\" href=\"UTD.htm?5/32/5641/abstract/41\">",
"     41",
"    </a>",
"    ]. Two weeks of lactose supplementation led to bacterial adaptation as evidenced by increased fecal beta-galactosidase activity and reduced breath hydrogen excretion after a lactose load. All symptoms except diarrhea regressed but equivalent clinical improvement occurred in the placebo group in which bacterial adaptation did not occur.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h2\">",
"     Relation of symptoms of lactose intolerance to lactose",
"    </span>",
"    &nbsp;&mdash;&nbsp;The symptoms associated with lactose ingestion may not necessarily be related to lactose malabsorption [",
"    <a class=\"abstract\" href=\"UTD.htm?5/32/5641/abstract/42\">",
"     42",
"    </a>",
"    ]. One study evaluated 30 subjects who complained of severe lactose intolerance who said they consistently developed symptoms after ingestion of less than 240 mL (8 oz) of milk [",
"    <a class=\"abstract\" href=\"UTD.htm?5/32/5641/abstract/34\">",
"     34",
"    </a>",
"    ]. The ability to digest lactose was assessed by a breath hydrogen test after a lactose load, which was abnormal in 21 subjects. Daily during breakfast, the subjects were then given 240 mL of lactose-hydrolyzed milk containing 2 percent fat or 240 mL of 2 percent fat milk that was sweetened with aspartame to simulate the taste of lactose-hydrolyzed milk. There was no difference in symptoms during the two study periods.",
"   </p>",
"   <p>",
"    The authors drew two conclusions: symptoms in lactose maldigesting subjects with severe intolerance may mistakenly be attributed to lactose; and symptoms are likely to be negligible if lactose intake is limited to the equivalent of 240 mL of milk per day. A subsequent report from the same group found that 240 mL of milk could be tolerated twice daily if given in widely divided doses with food [",
"    <a class=\"abstract\" href=\"UTD.htm?5/32/5641/abstract/37\">",
"     37",
"    </a>",
"    ]. However, one quart (946 mL) of milk (equivalent to 50 grams of lactose) usually induced symptoms in adults with malabsorption when administered as a single dose without meals [",
"    <a class=\"abstract\" href=\"UTD.htm?5/32/5641/abstract/43\">",
"     43",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Similar observations were made in a study of 45 African-Americans with documented lactose maldigestion and intolerance to less than 240 mL of milk [",
"    <a class=\"abstract\" href=\"UTD.htm?5/32/5641/abstract/44\">",
"     44",
"    </a>",
"    ]. Two-thirds reacted appropriately to the presence or absence of lactose in ingested milk, but one-third had equivalent symptoms with lactose-containing and low-lactose milk.",
"   </p>",
"   <p>",
"    Individuals with lactose malabsorption may still be able to tolerate a diet of calcium rich dairy products. A study involving women with lactose maldigestion demonstrated tolerance to a diet that provided 1500 mg of",
"    <span class=\"nowrap\">",
"     Ca/day",
"    </span>",
"    by a variety of dairy products (hard cheese, yogurt, and milk) that were spread throughout the day [",
"    <a class=\"abstract\" href=\"UTD.htm?5/32/5641/abstract/45\">",
"     45",
"    </a>",
"    ]. Another study involving adolescent girls with lactose maldigestion demonstrated that a dairy based diet providing 1200 mg of calcium per day was also well tolerated with negligible gastrointestinal symptoms [",
"    <a class=\"abstract\" href=\"UTD.htm?5/32/5641/abstract/46\">",
"     46",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    People with lactose intolerance often avoid taking medications in pill form because of the potential for lactose in the preparations to cause symptoms. In a study that addressed this issue, the investigators hypothesized that pills or tablets would be unlikely to contain more than 400 mg of lactose. They performed a randomized, cross-over, double-blind study that evaluated breath hydrogen production and symptoms in 77 lactose intolerant subjects after the ingestion of 400 mg of lactose or placebo [",
"    <a class=\"abstract\" href=\"UTD.htm?5/32/5641/abstract/47\">",
"     47",
"    </a>",
"    ]. Neither breath hydrogen levels nor symptoms were different when subjects ingested low-dose lactose than when they ingested placebo.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h1\">",
"     DIAGNOSIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;The term lactose malabsorption is generally reserved for those patients with typical symptoms in whom the intestinal malabsorption of lactose has been confirmed by a test of absorption (eg, lactose absorption test) or malabsorption (lactose breath hydrogen test). Less direct tests, such as low fecal pH or reducing substances in the stool, are only valid when lactose has been ingested, intestinal transit time is rapid, stools are collected fresh, assays are performed immediately, and bacterial metabolism of colonic carbohydrate is incomplete. The importance of confirming the diagnosis was illustrated in the preceding study of African Americans [",
"    <a class=\"abstract\" href=\"UTD.htm?5/32/5641/abstract/44\">",
"     44",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h2\">",
"     Lactose tolerance test",
"    </span>",
"    &nbsp;&mdash;&nbsp;The capacity for lactose absorption can be measured using a lactose absorption test. Following oral administration of a 50 g test dose in adults (or 2",
"    <span class=\"nowrap\">",
"     g/kg",
"    </span>",
"    in children), blood glucose levels are monitored at 0, 60, and 120 minutes. An increase in blood glucose by less than 20",
"    <span class=\"nowrap\">",
"     mg/dL",
"    </span>",
"    (1.1",
"    <span class=\"nowrap\">",
"     mmol/L)",
"    </span>",
"    plus the development of symptoms is diagnostic. False negative results may occur in patients with diabetes or bacterial overgrowth. Abnormal gastric emptying also can lead to spurious results; the blood glucose may be relatively higher with rapid emptying and depressed with delayed gastric emptying.",
"   </p>",
"   <p>",
"    In adults, the lactose tolerance test has a sensitivity of 75 percent and a specificity of 96 percent [",
"    <a class=\"abstract\" href=\"UTD.htm?5/32/5641/abstract/48\">",
"     48",
"    </a>",
"    ]. However, it is cumbersome (particularly in children) and time consuming, and has largely been replaced by the lactose breath hydrogen test.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h2\">",
"     Lactose breath hydrogen test",
"    </span>",
"    &nbsp;&mdash;&nbsp;The breath hydrogen test measures lactose nonabsorption. It is simple to perform, noninvasive, and has a sensitivity and specificity that are superior to the absorption test [",
"    <a class=\"abstract\" href=\"UTD.htm?5/32/5641/abstract/48,49\">",
"     48,49",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The test is begun by giving oral lactose in the fasting state, at a usual dose of 2",
"    <span class=\"nowrap\">",
"     g/kg",
"    </span>",
"    (maximum dose, 25 g). Breath hydrogen is sampled at baseline and at 30-minute intervals after the ingestion of lactose for three hours. The post-lactose and baseline values are compared. We generally consider a breath hydrogen value of 10 ppm (parts per million) as normal. Values between 10 and 20 ppm may be indeterminate unless accompanied by symptoms, while values over 20 ppm are considered diagnostic of lactose malabsorption.",
"   </p>",
"   <p>",
"    Both false-positive and false-negative results can occur. False-positive results are seen with inadequate pretest fasting or recent smoking; false-negative results can be seen after the recent use of antibiotics, in patients with lung disorders, or in the approximately 1 percent of subjects who are nonhydrogen producers. As noted above, intestinal",
"    <a class=\"drug drug_general\" href=\"UTD.htm?13/62/14306?source=see_link\">",
"     lactase",
"    </a>",
"    levels do not begin to fall until after age five. Thus, an abnormal lactose breath hydrogen test in children less than five years reflects either abnormal intestinal mucosa or bacterial overgrowth, both of which require further evaluation by appropriate diagnostic tests. A normal breath hydrogen test does not rule out an intestinal mucosal lesion and should not be used to avoid an intestinal biopsy.",
"   </p>",
"   <p>",
"    On the other hand, small bowel biopsy cannot necessarily establish the diagnosis of disaccharidase deficiency. Although low values can identify subjects at risk for symptomatic lactose intolerance, low",
"    <a class=\"drug drug_general\" href=\"UTD.htm?13/62/14306?source=see_link\">",
"     lactase",
"    </a>",
"    activity induced by intestinal injury may be missed if the lesion is focal or patchy. Thus, clinical and biochemical data must always be compared to establish the diagnosis.",
"   </p>",
"   <p>",
"    Once the diagnosis of lactose maldigestion is confirmed, the patient should be evaluated for one of the secondary causes described above (",
"    <a class=\"graphic graphic_table graphicRef71595 \" href=\"UTD.htm?12/0/12299\">",
"     table 1",
"    </a>",
"    ). Patients with a treatable underlying disorder may recover",
"    <a class=\"drug drug_general\" href=\"UTD.htm?13/62/14306?source=see_link\">",
"     lactase",
"    </a>",
"    activity and not require enzyme replacement. In infants and young children, the possibility of cow's milk protein intolerance should be excluded. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?33/52/34631?source=see_link\">",
"     \"Food protein-induced proctitis/colitis and enteropathy of infancy\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15\">",
"    <span class=\"h3\">",
"     Normal breath hydrogen tests",
"    </span>",
"    &nbsp;&mdash;&nbsp;A significant proportion of patients with symptoms suggestive of lactose intolerance have normal breath hydrogen tests. In two series described above, for example, 30 and 42 percent of subjects with severe symptoms of milk intolerance had normal tests [",
"    <a class=\"abstract\" href=\"UTD.htm?5/32/5641/abstract/34,44\">",
"     34,44",
"    </a>",
"    ]. Other possibilities that must be considered include psychologic factors [",
"    <a class=\"abstract\" href=\"UTD.htm?5/32/5641/abstract/36,37\">",
"     36,37",
"    </a>",
"    ] and intolerance to other components in milk.",
"   </p>",
"   <p>",
"    Some patients have symptoms similar to those of lactose intolerance that are related to the maldigestion of other simple carbohydrates (eg, fructose,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?29/0/29699?source=see_link\">",
"     sorbitol",
"    </a>",
"    ) or of complex carbohydrates (eg, high-fiber foods). Thus, a careful dietary history should be obtained and appropriate breath hydrogen testing or dietary modification performed.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16\">",
"    <span class=\"h3\">",
"     Genetic test for primary lactose malabsorption",
"    </span>",
"    &nbsp;&mdash;&nbsp;A test for the genetic polymorphism associated with the previously mentioned polymorphism that is 13.9 kb upstream from the 5' end of the",
"    <a class=\"drug drug_general\" href=\"UTD.htm?13/62/14306?source=see_link\">",
"     lactase",
"    </a>",
"    transcriptional start site has been developed [",
"    <a class=\"abstract\" href=\"UTD.htm?5/32/5641/abstract/50\">",
"     50",
"    </a>",
"    ]. In one study, lactase enzyme levels obtained during duodenal biopsies as the \"gold standard\" for lactase status were compared to the genetic variant with",
"    <span class=\"nowrap\">",
"     C/C-13910.",
"    </span>",
"    The majority of 8 year-olds and all children over 12 years of age had a tight correlation between the",
"    <span class=\"nowrap\">",
"     C/C",
"    </span>",
"    variant and low lactase activity. Sensitivity and specificity were 93 and 100 percent, respectively, which is comparable to the accuracy of the lactose tolerance test and breath hydrogen tests. However, the test is expensive and may not be covered by the patient's insurance. Furthermore, the test may not be useful for patients of African origin [",
"    <a class=\"abstract\" href=\"UTD.htm?5/32/5641/abstract/6,13\">",
"     6,13",
"    </a>",
"    ]. We generally prefer the lactose breath hydrogen test.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17\">",
"    <span class=\"h1\">",
"     TREATMENT",
"    </span>",
"    &nbsp;&mdash;&nbsp;As lactose intolerance is usually not a disease, the \"treatment\" really focuses on eliminating symptoms, while helping the patient adapt to a gradual increase in lactose intake. Nevertheless, the approach to the patient with lactose malabsorption in the absence of a correctable underlying disease includes four general principles:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Reduced dietary lactose intake",
"     </li>",
"     <li>",
"      Substitution of alternative nutrient sources to maintain energy and protein intake",
"     </li>",
"     <li>",
"      Administration of a commercially available enzyme substitute.",
"     </li>",
"     <li>",
"      Maintenance of calcium and vitamin D intake",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H18\">",
"    <span class=\"h2\">",
"     Dietary lactose restriction",
"    </span>",
"    &nbsp;&mdash;&nbsp;When lactose restriction is necessary, the patient (or his or her parents) must be instructed to read labels of commercially prepared foods, as hidden lactose may be difficult to identify. By far the highest concentration of lactose per serving is present in milk and ice cream (",
"    <a class=\"graphic graphic_table graphicRef54826 \" href=\"UTD.htm?35/25/36252\">",
"     table 2",
"    </a>",
"    ). Cheeses generally contain much lower quantities. Information on effective label reading is presented separately (see",
"    <a class=\"medical medical_review\" href=\"UTD.htm?17/48/18185?source=see_link\">",
"     \"Management of food allergy: Avoidance\"",
"    </a>",
"    ).",
"   </p>",
"   <p>",
"    Complete restriction of lactose-containing foods should only be necessary for a limited period to ascertain the specificity of the diagnosis. Since some patients can tolerate graded increases in lactose intake, small quantities of lactose may subsequently be reintroduced into the diet, with careful attention being paid to development of associated symptoms. Because of its high sugar and fat content, ice cream may be a good way to introduce lactose into the diet. The diet should be reviewed with the patient to be certain that protein, fat, and other nutrients are supplied at appropriate levels.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H19\">",
"    <span class=\"h2\">",
"     Enzyme replacement",
"    </span>",
"    &nbsp;&mdash;&nbsp;Commercially available \"",
"    <a class=\"drug drug_general\" href=\"UTD.htm?13/62/14306?source=see_link\">",
"     lactase",
"    </a>",
"    \" preparations are actually bacterial or yeast beta-galactosidases. These supplements can, when added to lactose-containing food or ingested with meals containing lactose, reduce symptoms and breath hydrogen values in many lactose intolerant subjects. However, these products are not capable of completely hydrolyzing all dietary lactose, and the results achieved in individual patients are variable.",
"   </p>",
"   <p>",
"    Among the commercial \"",
"    <a class=\"drug drug_general\" href=\"UTD.htm?13/62/14306?source=see_link\">",
"     lactase",
"    </a>",
"    \" preparations are Lactaid (tablets or liquid), Lactrase, LactAce, DairyEase, and Lactrol. Lactaid liquid can be added to milk (14",
"    <span class=\"nowrap\">",
"     drops/quart)",
"    </span>",
"    which is then refrigerated overnight before use. The resulting hydrolysis of lactose (which is virtually 100 percent effective) produces a sweeter taste than milk containing lactose [",
"    <a class=\"abstract\" href=\"UTD.htm?5/32/5641/abstract/51\">",
"     51",
"    </a>",
"    ]. Commercially available predigested dairy products (eg, Lactaid milk) are also available.",
"   </p>",
"   <p>",
"    Lactrase capsules can be sprinkled on or taken orally with lactose-containing foods, as can some of the other",
"    <a class=\"drug drug_general\" href=\"UTD.htm?13/62/14306?source=see_link\">",
"     lactase",
"    </a>",
"    preparations; however, the individual doses required and responses to individual products must be tested in each patient. \"Acidophilus milk\" is not sufficiently lactose-depleted to be useful.",
"   </p>",
"   <p>",
"    It is possible that the efficacy of the different \"",
"    <a class=\"drug drug_general\" href=\"UTD.htm?13/62/14306?source=see_link\">",
"     lactase",
"    </a>",
"    \" preparations is not equivalent. A randomized, controlled trial compared the efficacy of three lactase preparations: Lactaid, Lactrase, and DairyEase [",
"    <a class=\"abstract\" href=\"UTD.htm?5/32/5641/abstract/52\">",
"     52",
"    </a>",
"    ]. The results illustrated some of the difficulties in dissociation between objective measures (breath hydrogen) and subjective symptoms as noted above. Only Lactaid reduced breath hydrogen after a lactose load; however, Lactaid did not improve symptoms. On the other hand, Lactrase, which did not reduce breath hydrogen, diminished pain, bloating, and total symptom scores, while Dairy Ease only improved pain. We generally recommend that individuals who have lactose intolerance start with two Lactaid tablets with lactose ingestion, and adjust both the Lactaid dose and the lactose load to tolerance.",
"   </p>",
"   <p>",
"    Live culture yogurt, which contains endogenous beta-galactosidase, is an alternative source of calories and calcium, and may be well-tolerated by many lactose-intolerant patients. However, yogurts that contain milk or milk products added back after fermentation (such as many of the commercially available yogurt products in the United States) may produce symptoms.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H20\">",
"    <span class=\"h2\">",
"     Probiotics",
"    </span>",
"    &nbsp;&mdash;&nbsp;Ingestion of",
"    <a class=\"drug drug_general\" href=\"UTD.htm?13/62/14306?source=see_link\">",
"     lactase",
"    </a>",
"    -containing probiotics has the potential to aid lactose digestion in patients with lactose intolerance. However, studies evaluating a potential benefit have produced discordant results; thus their role remains unproven. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?16/10/16554?source=see_link\">",
"     \"Probiotics for gastrointestinal diseases\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H21\">",
"    <span class=\"h2\">",
"     Calcium intake",
"    </span>",
"    &nbsp;&mdash;&nbsp;Avoidance of milk and other dairy products can lead to reduced calcium intake, which may increase the risk for osteoporosis and fracture [",
"    <a class=\"abstract\" href=\"UTD.htm?5/32/5641/abstract/53\">",
"     53",
"    </a>",
"    ]. One report demonstrated a strong correlation between bone mineral density values with the severity of symptoms and calcium intake in lactose intolerant young adults [",
"    <a class=\"abstract\" href=\"UTD.htm?5/32/5641/abstract/53\">",
"     53",
"    </a>",
"    ]. In another study that focused on lactose intolerant Finnish women, mean calcium intake was significantly lower than in other women (570 versus 850",
"    <span class=\"nowrap\">",
"     mg/day)",
"    </span>",
"    and the adjusted odds ratio for non-ankle lower body fractures was 2.15 [",
"    <a class=\"abstract\" href=\"UTD.htm?5/32/5641/abstract/54\">",
"     54",
"    </a>",
"    ]. In a group of 30 pediatric patients (age 2 to 14) who had lactose restriction secondary to lactose intolerance, milk protein allergy, or hypercholesterolemia (mean Ca intake 270",
"    <span class=\"nowrap\">",
"     mg/day)",
"    </span>",
"    for two years, nine developed osteoporosis and six developed osteopenia [",
"    <a class=\"abstract\" href=\"UTD.htm?5/32/5641/abstract/55\">",
"     55",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    We typically use",
"    <a class=\"drug drug_general\" href=\"UTD.htm?41/32/42504?source=see_link\">",
"     calcium carbonate",
"    </a>",
"    for calcium supplementation because it is the cheapest form available. Tums&trade; is popular and effective. Viactiv&trade; is also convenient, although it does contain 0.5 g of lactose per cube, likely too low to produce symptoms. In infants and young children, liquid",
"    <a class=\"drug drug_general\" href=\"UTD.htm?18/11/18616?source=see_link\">",
"     calcium gluconate",
"    </a>",
"    is readily tolerated and available. When complete lactose restriction is recommended, the USRDA for calcium should be provided as a supplement.",
"   </p>",
"   <p>",
"    Calcium supplementation in excess of 500",
"    <span class=\"nowrap\">",
"     mg/day",
"    </span>",
"    should be given in",
"    <strong>",
"     divided doses",
"    </strong>",
"    . We recommend approximately 1200-1500",
"    <span class=\"nowrap\">",
"     mg/day",
"    </span>",
"    for adolescents and young adults. Recommendations in adults depend upon gender and menopausal status. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?11/56/12170?source=see_link\">",
"     \"Calcium and vitamin D supplementation in osteoporosis\"",
"    </a>",
"    .) Higher individual doses are associated with a plateau in calcium absorption that may prevent the attainment of positive calcium balance (",
"    <a class=\"graphic graphic_figure graphicRef59783 \" href=\"UTD.htm?31/47/32509\">",
"     figure 1",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?5/32/5641/abstract/56\">",
"     56",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The absorption of",
"    <a class=\"drug drug_general\" href=\"UTD.htm?41/32/42504?source=see_link\">",
"     calcium carbonate",
"    </a>",
"    , but not",
"    <a class=\"drug drug_general\" href=\"UTD.htm?37/46/38628?source=see_link\">",
"     calcium citrate",
"    </a>",
"    , is poor in patients with achlorhydria unless taken with meals [",
"    <a class=\"abstract\" href=\"UTD.htm?5/32/5641/abstract/57\">",
"     57",
"    </a>",
"    ]. Although it might seem prudent to take calcium carbonate with meals, since it is often difficult to know who has achlorhydria, there is some evidence suggesting that taking calcium supplements with meals reduces iron absorption from food by about 50 percent. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?11/56/12170?source=see_link\">",
"     \"Calcium and vitamin D supplementation in osteoporosis\"",
"    </a>",
"    .) As a result, we usually recommend that patients take calcium carbonate with a low-iron meal (such as breakfast) to avoid possible iron deficiency. An alternative is calcium citrate (Citracal).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H22\">",
"    <span class=\"h2\">",
"     Vitamin D intake",
"    </span>",
"    &nbsp;&mdash;&nbsp;The vitamin D status of patients with restricted intake of dairy products should be monitored. In a survey of healthy adolescents, 24 percent of attendees in an urban hospital in Boston were found to be vitamin D deficient [",
"    <a class=\"abstract\" href=\"UTD.htm?5/32/5641/abstract/58\">",
"     58",
"    </a>",
"    ]. Factors associated with higher vitamin D levels were intake of multivitamins and milk consumption. Factors associated with lower vitamin D levels were juice and soft drink consumption, higher BMI, and African American ethnicity. Thus, vitamin D supplementation and monitoring of vitamin D status should be provided for patients who restrict milk intake, and especially those at high risk such as patients with malabsorption, Crohn's disease, or celiac disease.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"PATIENT_INFORMATION\">",
"    <span class=\"h1\">",
"     INFORMATION FOR PATIENTS",
"    </span>",
"    &nbsp;&mdash;&nbsp;UpToDate offers two types of patient education materials, \"The Basics\" and \"Beyond the Basics.\" The Basics patient education pieces are written in plain language, at the 5",
"    <sup>",
"     th",
"    </sup>",
"    to 6",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10",
"    <sup>",
"     th",
"    </sup>",
"    to 12",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.",
"   </p>",
"   <p>",
"    Here are the patient education articles that are relevant to this topic. We encourage you to print or e-mail these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on \"patient info\" and the keyword(s) of interest.)",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Basics topics (see",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?21/31/22002?source=see_link\">",
"       \"Patient information: Gas and bloating (The Basics)\"",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      Beyond the Basics topics (see",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?11/26/11684?source=see_link\">",
"       \"Patient information: Lactose intolerance (The Basics)\"",
"      </a>",
"      and",
"      <a class=\"medical medical_patient\" href=\"UTD.htm?6/14/6371?source=see_link\">",
"       \"Patient information: Gas and bloating (Beyond the Basics)\"",
"      </a>",
"      )",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2164180\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The term lactose intolerance is applied to the development of characteristic symptoms after the ingestion of lactose: abdominal pain, bloating, flatulence, diarrhea, and, particularly in adolescents, vomiting. (See",
"      <a class=\"local\" href=\"#H10\">",
"       'Clinical manifestations'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Intolerance to lactose-containing foods (primarily dairy products) is common. In Europe and the United States, the prevalence is 7 to 20 percent in Caucasian adults (being lowest in those of northern European extraction), and is as high as 80 to 95 percent among Native Americans, 65 to 75 percent among Africans and African Americans, and 50 percent in Hispanics. The prevalence exceeds 90 percent in some populations in eastern Asia. (See",
"      <a class=\"local\" href=\"#H1\">",
"       'Introduction'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The causes of lactose malabsorption can be divided into primary",
"      <a class=\"drug drug_general\" href=\"UTD.htm?13/62/14306?source=see_link\">",
"       lactase",
"      </a>",
"      deficiency and lactase deficiency induced by underlying intestinal disease (",
"      <a class=\"graphic graphic_table graphicRef71595 \" href=\"UTD.htm?12/0/12299\">",
"       table 1",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H5\">",
"       'Etiology of lactose malabsorption'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The term lactose malabsorption is generally reserved for those patients with typical symptoms in whom the intestinal malabsorption of lactose has been confirmed by a test of absorption (eg, lactose absorption test) or malabsorption (lactose breath hydrogen test). (See",
"      <a class=\"local\" href=\"#H12\">",
"       'Diagnosis'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The approach to patients with lactose malabsorption in the absence of a correctable underlying disease includes four general principles (see",
"      <a class=\"local\" href=\"#H17\">",
"       'Treatment'",
"      </a>",
"      above):",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      Reduced dietary lactose intake",
"     </li>",
"     <li>",
"      Substitution of alternative nutrient sources to maintain energy and protein intake",
"     </li>",
"     <li>",
"      Administration of a commercially available enzyme substitute.",
"     </li>",
"     <li>",
"      Maintenance of calcium and vitamin D intake",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/32/5641/abstract/1\">",
"      Caspary WF. Diarrhoea associated with carbohydrate malabsorption. Clin Gastroenterol 1986; 15:631.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/32/5641/abstract/2\">",
"      Scrimshaw NS, Murray EB. The acceptability of milk and milk products in populations with a high prevalence of lactose intolerance. Am J Clin Nutr 1988; 48:1079.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/32/5641/abstract/3\">",
"      Maiuri L, Raia V, Potter J, et al. Mosaic pattern of lactase expression by villous enterocytes in human adult-type hypolactasia. Gastroenterology 1991; 100:359.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/32/5641/abstract/4\">",
"      Mart&iacute;n MG, Turk E, Lostao MP, et al. Defects in Na+/glucose cotransporter (SGLT1) trafficking and function cause glucose-galactose malabsorption. Nat Genet 1996; 12:216.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/32/5641/abstract/5\">",
"      Shaw AD, Davies GJ. Lactose intolerance: problems in diagnosis and treatment. J Clin Gastroenterol 1999; 28:208.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/32/5641/abstract/6\">",
"      Tishkoff SA, Reed FA, Ranciaro A, et al. Convergent adaptation of human lactase persistence in Africa and Europe. Nat Genet 2007; 39:31.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/32/5641/abstract/7\">",
"      Sahi T, Isokoski M, Jussila J, et al. Recessive inheritance of adult-type lactose malabsorption. Lancet 1973; 2:823.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/32/5641/abstract/8\">",
"      Harvey CB, Hollox EJ, Poulter M, et al. Lactase haplotype frequencies in Caucasians: association with the lactase persistence/non-persistence polymorphism. Ann Hum Genet 1998; 62:215.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/32/5641/abstract/9\">",
"      Enattah NS, Sahi T, Savilahti E, et al. Identification of a variant associated with adult-type hypolactasia. Nat Genet 2002; 30:233.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/32/5641/abstract/10\">",
"      Kuokkanen M, Enattah NS, Oksanen A, et al. Transcriptional regulation of the lactase-phlorizin hydrolase gene by polymorphisms associated with adult-type hypolactasia. Gut 2003; 52:647.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/32/5641/abstract/11\">",
"      Olds LC, Sibley E. Lactase persistence DNA variant enhances lactase promoter activity in vitro: functional role as a cis regulatory element. Hum Mol Genet 2003; 12:2333.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/32/5641/abstract/12\">",
"      Troelsen JT, Olsen J, M&oslash;ller J, Sj&ouml;str&ouml;m H. An upstream polymorphism associated with lactase persistence has increased enhancer activity. Gastroenterology 2003; 125:1686.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/32/5641/abstract/13\">",
"      Lewinsky RH, Jensen TG, M&oslash;ller J, et al. T-13910 DNA variant associated with lactase persistence interacts with Oct-1 and stimulates lactase promoter activity in vitro. Hum Mol Genet 2005; 14:3945.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/32/5641/abstract/14\">",
"      Mulcare CA, Weale ME, Jones AL, et al. The T allele of a single-nucleotide polymorphism 13.9 kb upstream of the lactase gene (LCT) (C-13.9kbT) does not predict or cause the lactase-persistence phenotype in Africans. Am J Hum Genet 2004; 74:1102.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/32/5641/abstract/15\">",
"      Troelsen JT, Mehlum A, Olsen J, et al. 1 kb of the lactase-phlorizin hydrolase promoter directs post-weaning decline and small intestinal-specific expression in transgenic mice. FEBS Lett 1994; 342:291.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/32/5641/abstract/16\">",
"      Krasinski SD, Upchurch BH, Irons SJ, et al. Rat lactase-phlorizin hydrolase/human growth hormone transgene is expressed on small intestinal villi in transgenic mice. Gastroenterology 1997; 113:844.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/32/5641/abstract/17\">",
"      Fang R, Santiago NA, Olds LC, Sibley E. The homeodomain protein Cdx2 regulates lactase gene promoter activity during enterocyte differentiation. Gastroenterology 2000; 118:115.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/32/5641/abstract/18\">",
"      Krasinski SD, Van Wering HM, Tannemaat MR, Grand RJ. Differential activation of intestinal gene promoters: functional interactions between GATA-5 and HNF-1 alpha. Am J Physiol Gastrointest Liver Physiol 2001; 281:G69.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/32/5641/abstract/19\">",
"      Troelsen JT. Adult-type hypolactasia and regulation of lactase expression. Biochim Biophys Acta 2005; 1723:19.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/32/5641/abstract/20\">",
"      Escher JC, de Koning ND, van Engen CG, et al. Molecular basis of lactase levels in adult humans. J Clin Invest 1992; 89:480.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/32/5641/abstract/21\">",
"      Fajardo O, Naim HY, Lacey SW. The polymorphic expression of lactase in adults is regulated at the messenger RNA level. Gastroenterology 1994; 106:1233.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/32/5641/abstract/22\">",
"      Rossi M, Maiuri L, Fusco MI, et al. Lactase persistence versus decline in human adults: multifactorial events are involved in down-regulation after weaning. Gastroenterology 1997; 112:1506.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/32/5641/abstract/23\">",
"      Lorenzsonn V, Lloyd M, Olsen WA. Immunocytochemical heterogeneity of lactase-phlorizin hydrolase in adult lactase deficiency. Gastroenterology 1993; 105:51.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/32/5641/abstract/24\">",
"      Rao DR, Bello H, Warren AP, Brown GE. Prevalence of lactose maldigestion. Influence and interaction of age, race, and sex. Dig Dis Sci 1994; 39:1519.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/32/5641/abstract/25\">",
"      Di Stefano M, Veneto G, Malservisi S, et al. Lactose malabsorption and intolerance in the elderly. Scand J Gastroenterol 2001; 36:1274.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/32/5641/abstract/26\">",
"      Mobassaleh M, Montgomery RK, Biller JA, Grand RJ. Development of carbohydrate absorption in the fetus and neonate. Pediatrics 1985; 75:160.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/32/5641/abstract/27\">",
"      J&auml;rvel&auml; I, Enattah NS, Kokkonen J, et al. Assignment of the locus for congenital lactase deficiency to 2q21, in the vicinity of but separate from the lactase-phlorizin hydrolase gene. Am J Hum Genet 1998; 63:1078.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/32/5641/abstract/28\">",
"      Kuokkanen M, Kokkonen J, Enattah NS, et al. Mutations in the translated region of the lactase gene (LCT) underlie congenital lactase deficiency. Am J Hum Genet 2006; 78:339.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/32/5641/abstract/29\">",
"      Saarela T, Simil&auml; S, Koivisto M. Hypercalcemia and nephrocalcinosis in patients with congenital lactase deficiency. J Pediatr 1995; 127:920.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/32/5641/abstract/30\">",
"      Mishkin B, Yalovsky M, Mishkin S. Increased prevalence of lactose malabsorption in Crohn's disease patients at low risk for lactose malabsorption based on ethnic origin. Am J Gastroenterol 1997; 92:1148.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/32/5641/abstract/31\">",
"      Kirschner BS, DeFavaro MV, Jensen W. Lactose malabsorption in children and adolescents with inflammatory bowel disease. Gastroenterology 1981; 81:829.",
"     </a>",
"    </li>",
"    <li>",
"     Buller HA, Grand RJ. Lactose intolerance. In: Annual Review of Medicine: Selected Topics in the Clinical Sciences, Creger WP, Coggins CH, Hancock EW (Eds), Annual Reviews Inc, Palo Alto 1990. p.141.",
"    </li>",
"    <li>",
"     Montgomery, R, Buller, HA, Rings, EH, et al. Lactose intolerance and regulation of small intestine lactase activity. In: Nutrition and Gene Expression, Berdanier, CD, Hargrove, JL (Eds), CRC Press, Boca Raton 1992. p.23.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/32/5641/abstract/34\">",
"      Suarez FL, Savaiano DA, Levitt MD. A comparison of symptoms after the consumption of milk or lactose-hydrolyzed milk by people with self-reported severe lactose intolerance. N Engl J Med 1995; 333:1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/32/5641/abstract/35\">",
"      Serra J, Azpiroz F, Malagelada JR. Intestinal gas dynamics and tolerance in humans. Gastroenterology 1998; 115:542.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/32/5641/abstract/36\">",
"      Vesa TH, Seppo LM, Marteau PR, et al. Role of irritable bowel syndrome in subjective lactose intolerance. Am J Clin Nutr 1998; 67:710.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/32/5641/abstract/37\">",
"      Suarez FL, Savaiano D, Arbisi P, Levitt MD. Tolerance to the daily ingestion of two cups of milk by individuals claiming lactose intolerance. Am J Clin Nutr 1997; 65:1502.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/32/5641/abstract/38\">",
"      B&ouml;hmer CJ, Tuynman HA. The effect of a lactose-restricted diet in patients with a positive lactose tolerance test, earlier diagnosed as irritable bowel syndrome: a 5-year follow-up study. Eur J Gastroenterol Hepatol 2001; 13:941.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/32/5641/abstract/39\">",
"      Vernia P, Marinaro V, Argnani F, et al. Self-reported milk intolerance in irritable bowel syndrome: what should we believe? Clin Nutr 2004; 23:996.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/32/5641/abstract/40\">",
"      Hertzler SR, Savaiano DA. Colonic adaptation to daily lactose feeding in lactose maldigesters reduces lactose intolerance. Am J Clin Nutr 1996; 64:232.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/32/5641/abstract/41\">",
"      Briet F, Pochart P, Marteau P, et al. Improved clinical tolerance to chronic lactose ingestion in subjects with lactose intolerance: a placebo effect? Gut 1997; 41:632.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/32/5641/abstract/42\">",
"      Yang J, Deng Y, Chu H, et al. Prevalence and presentation of lactose intolerance and effects on dairy product intake in healthy subjects and patients with irritable bowel syndrome. Clin Gastroenterol Hepatol 2013; 11:262.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/32/5641/abstract/43\">",
"      Suchy FJ, Brannon PM, Carpenter TO, et al. National Institutes of Health Consensus Development Conference: lactose intolerance and health. Ann Intern Med 2010; 152:792.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/32/5641/abstract/44\">",
"      Johnson AO, Semenya JG, Buchowski MS, et al. Correlation of lactose maldigestion, lactose intolerance, and milk intolerance. Am J Clin Nutr 1993; 57:399.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/32/5641/abstract/45\">",
"      Suarez FL, Adshead J, Furne JK, Levitt MD. Lactose maldigestion is not an impediment to the intake of 1500 mg calcium daily as dairy products. Am J Clin Nutr 1998; 68:1118.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/32/5641/abstract/46\">",
"      Pribila BA, Hertzler SR, Martin BR, et al. Improved lactose digestion and intolerance among African-American adolescent girls fed a dairy-rich diet. J Am Diet Assoc 2000; 100:524.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/32/5641/abstract/47\">",
"      Montalto M, Gallo A, Santoro L, et al. Low-dose lactose in drugs neither increases breath hydrogen excretion nor causes gastrointestinal symptoms. Aliment Pharmacol Ther 2008; 28:1003.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/32/5641/abstract/48\">",
"      Newcomer AD, McGill DB, Thomas PJ, Hofmann AF. Prospective comparison of indirect methods for detecting lactase deficiency. N Engl J Med 1975; 293:1232.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/32/5641/abstract/49\">",
"      Joseph F, Rosenberg AJ. Identifying lactose malabsorbers through breath hydrogen measurements. Lab Med 1986; 17:85.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/32/5641/abstract/50\">",
"      Rasinper&auml; H, Savilahti E, Enattah NS, et al. A genetic test which can be used to diagnose adult-type hypolactasia in children. Gut 2004; 53:1571.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/32/5641/abstract/51\">",
"      Rosado JL, Solomons NW, Lisker R, Bourges H. Enzyme replacement therapy for primary adult lactase deficiency. Effective reduction of lactose malabsorption and milk intolerance by direct addition of beta-galactosidase to milk at mealtime. Gastroenterology 1984; 87:1072.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/32/5641/abstract/52\">",
"      Ramirez FC, Lee K, Graham DY. All lactase preparations are not the same: results of a prospective, randomized, placebo-controlled trial. Am J Gastroenterol 1994; 89:566.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/32/5641/abstract/53\">",
"      Di Stefano M, Veneto G, Malservisi S, et al. Lactose malabsorption and intolerance and peak bone mass. Gastroenterology 2002; 122:1793.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/32/5641/abstract/54\">",
"      Honkanen R, Kr&ouml;ger H, Alhava E, et al. Lactose intolerance associated with fractures of weight-bearing bones in Finnish women aged 38-57 years. Bone 1997; 21:473.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/32/5641/abstract/55\">",
"      Infante D, Tormo R. Risk of inadequate bone mineralization in diseases involving long-term suppression of dairy products. J Pediatr Gastroenterol Nutr 2000; 30:310.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/32/5641/abstract/56\">",
"      Harvey JA, Zobitz MM, Pak CY. Dose dependency of calcium absorption: a comparison of calcium carbonate and calcium citrate. J Bone Miner Res 1988; 3:253.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/32/5641/abstract/57\">",
"      Sheikh MS, Santa Ana CA, Nicar MJ, et al. Gastrointestinal absorption of calcium from milk and calcium salts. N Engl J Med 1987; 317:532.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/32/5641/abstract/58\">",
"      Gordon CM, DePeter KC, Feldman HA, et al. Prevalence of vitamin D deficiency among healthy adolescents. Arch Pediatr Adolesc Med 2004; 158:531.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 2542 Version 9.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1004-115.25.216.6-7AD06D259D-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f5_32_5641=[""].join("\n");
var outline_f5_32_5641=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H2164180\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      LACTOSE INTAKE",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      LACTOSE DIGESTION",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      Colonic salvage of nonabsorbed lactose",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      ETIOLOGY OF LACTOSE MALABSORPTION",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      Racial or ethnic lactose malabsorption",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      Developmental lactase deficiency",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      Congenital lactase deficiency",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      Secondary lactose malabsorption",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      CLINICAL MANIFESTATIONS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      Relation of symptoms of lactose intolerance to lactose",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      DIAGNOSIS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      Lactose tolerance test",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      Lactose breath hydrogen test",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H15\">",
"      - Normal breath hydrogen tests",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H16\">",
"      - Genetic test for primary lactose malabsorption",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H17\">",
"      TREATMENT",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H18\">",
"      Dietary lactose restriction",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H19\">",
"      Enzyme replacement",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H20\">",
"      Probiotics",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H21\">",
"      Calcium intake",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H22\">",
"      Vitamin D intake",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#PATIENT_INFORMATION\">",
"      INFORMATION FOR PATIENTS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2164180\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"GAST/2542\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"GAST/2542|FIG\">",
"      <a href=\"#\" title=\"FIGURES\">",
"       FIGURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?31/47/32509\" title=\"figure 1\">",
"      Calcium dose and absorption",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"GAST/2542|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?12/0/12299\" title=\"table 1\">",
"      Causes of lactose malabsorption",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?35/25/36252\" title=\"table 2\">",
"      Lactose content",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?11/56/12170?source=related_link\">",
"      Calcium and vitamin D supplementation in osteoporosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?33/52/34631?source=related_link\">",
"      Food protein-induced proctitis/colitis and enteropathy of infancy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?17/48/18185?source=related_link\">",
"      Management of food allergy: Avoidance",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?6/14/6371?source=related_link\">",
"      Patient information: Gas and bloating (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?21/31/22002?source=related_link\">",
"      Patient information: Gas and bloating (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?11/26/11684?source=related_link\">",
"      Patient information: Lactose intolerance (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?16/10/16554?source=related_link\">",
"      Probiotics for gastrointestinal diseases",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f5_32_5642="Functional anatomy of the finger";
var content_f5_32_5642=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=EM%2F51038&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=5\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=EM%2F51038&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=5\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 611px\">",
"   <div class=\"ttl\">",
"    Functional anatomy of the finger",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 591px; height: 750px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Dorsal \"hood\" and extensor expansion of the 3rd digit. Lateral (A) and posterior (B) views of the dorsal \"hood\" and extensor expansion. Observe the interosseous muscles inserted in part into the base of the proximal phalanx and in part into the extensor expansion and the lumbrical muscle, which inserts into the radial side of the extensor expansion. (C-D) Lateral views of the extensor expansion in extension. The extensor expansion is a delicate fibrous band that runs from the proximal phalanx and fibrous digital sheath obliquely across the middle phalanx and two interphalangeal joints to join the dorsal \"hood\" to the distal phalanx. (E) Lateral view of the finger in flexion. On flexing the distal interphalangeal joint (C), the extensor expansion (particularly its lateral bands) becomes taut, pulling the proximal joint into flexion (E). Similarly, on flexing the metacarpophalangeal joint, the proximal and distal joints are pulled by the extensor expansions (lateral bands) into nearly complete extension.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: Moore KL, PhD, FRSM, FIAC &amp; Dalley AF II, PhD. Clinical Oriented Anatomy (4th ed). Baltimore, Lippincott Williams &amp; Wilkins 1999. Copyright &copy; 1999 Lippincott Williams &amp; Wilkins.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f5_32_5642=[""].join("\n");
var outline_f5_32_5642=null;
var title_f5_32_5643="Endocrine and metabolic causes of constipation in children";
var content_f5_32_5643=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PEDS%2F70206&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PEDS%2F70206&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Endocrine and metabolic causes of constipation in infants and children",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td>",
"        Hypokalemia",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Hypo- or hypercalcemia",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Hypothyroidism",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Diabetes mellitus",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Pheochromocytoma",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Polyuria (leading to dehydration)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Amyloidosis",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Acute intermittent porphyria",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Data from: Tunnessen WJ. Constipation and fecal retention. In: Signs and Symptoms in Pediatrics, 3rd ed, Lippincott, Williams &amp; Wilkins, Philadelphia 1999. p.518.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f5_32_5643=[""].join("\n");
var outline_f5_32_5643=null;
var title_f5_32_5644="Long term anticoagulation after ICH";
var content_f5_32_5644=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=HEME%2F72853&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=HEME%2F72853&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Long-term anticoagulation of survivors of warfarin-associated intracerebral hemorrhage",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1\">",
"        Study",
"       </td>",
"       <td class=\"subtitle1\">",
"        N",
"       </td>",
"       <td class=\"subtitle1\">",
"        Mean age",
"       </td>",
"       <td class=\"subtitle1\">",
"        Indication",
"       </td>",
"       <td class=\"subtitle1\">",
"        Target INR",
"       </td>",
"       <td class=\"subtitle1\">",
"        Mean follow-up",
"       </td>",
"       <td class=\"subtitle1\">",
"        Outcome",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Punthakee, et al. (2003)",
"       </td>",
"       <td>",
"        6",
"       </td>",
"       <td>",
"        ~64 y/o",
"       </td>",
"       <td>",
"        Prosthetic valves",
"       </td>",
"       <td>",
"        NR",
"       </td>",
"       <td>",
"        34 months",
"       </td>",
"       <td>",
"        No ICH",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Butler and Tait (1998)",
"       </td>",
"       <td>",
"        4",
"       </td>",
"       <td>",
"        ~57 y/o",
"       </td>",
"       <td>",
"        Prosthetic valves",
"       </td>",
"       <td>",
"        2-3, 2.5-3, 3-3.5, 3-4.5",
"       </td>",
"       <td>",
"        22 months",
"       </td>",
"       <td>",
"        No ICH",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Lau, et al. (1991)",
"       </td>",
"       <td>",
"        1",
"       </td>",
"       <td>",
"        ~65 y/o",
"       </td>",
"       <td>",
"        Prosthetic valve",
"       </td>",
"       <td>",
"        1.8-2.5",
"       </td>",
"       <td>",
"        36 months",
"       </td>",
"       <td>",
"        No ICH",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Classeen, et al. (2008)",
"       </td>",
"       <td>",
"        23",
"       </td>",
"       <td>",
"        71 y/o",
"       </td>",
"       <td>",
"        Multiple*",
"       </td>",
"       <td>",
"        NR",
"       </td>",
"       <td>",
"        50 months",
"       </td>",
"       <td>",
"        3 CNS bleeds&bull;",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"     ICH: intracerebral hemorrhage; NR: not reported.",
"     <br>",
"      * Prosthetic valves in 10, atrial fibrillation in nine, venous thromboembolism in three.",
"      <br>",
"       <span class=\"bullet\">",
"        &bull;",
"       </span>",
"       One fatal intracerebral hemorrhage, one nonfatal subdural hematoma, one fatal traumatic subarachnoid hemorrhage.",
"      </br>",
"     </br>",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f5_32_5644=[""].join("\n");
var outline_f5_32_5644=null;
var title_f5_32_5645="Differentiation of foot ulcers";
var content_f5_32_5645=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=CARD%2F63577&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=CARD%2F63577&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Differentiation of foot ulcers",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <colgroup span=\"4\" width=\"25%\">",
"     </colgroup>",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1\">",
"        Characteristic",
"       </td>",
"       <td class=\"subtitle1\">",
"        Arterial ulcer*",
"       </td>",
"       <td class=\"subtitle1\">",
"        Venous ulcer",
"       </td>",
"       <td class=\"subtitle1\">",
"        Neuropathic ulcer*",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Location",
"       </td>",
"       <td>",
"        Over toe joints, malleoli (over the bony prominence), anterior shin, base of heel, pressure points",
"       </td>",
"       <td>",
"        Medial and lateral malleolar area above bony prominence, posterior calf, may be large, circumferential",
"       </td>",
"       <td>",
"        Plantar surface of foot over metatarsal heads, heel, pressure points",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Appearance",
"       </td>",
"       <td>",
"        Irregular margins, base dry and often pale or necrotic (brown/black fibrous tissue)",
"       </td>",
"       <td>",
"        Irregular margins, pink or red base that may be covered with yellow fibrinous tissue, exudate common (may be heavy); ulcers can be large, sometimes circumferential",
"       </td>",
"       <td>",
"        Punched out ulcer, usually superficial but sometimes deep, red base",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Ulcer within callus",
"       </td>",
"       <td>",
"        Rare",
"       </td>",
"       <td>",
"        No",
"       </td>",
"       <td>",
"        Calloused border, ulcer can be underlying a callus",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Foot temperature",
"       </td>",
"       <td>",
"        Warm or cool",
"       </td>",
"       <td>",
"        Warm",
"       </td>",
"       <td>",
"        Warm",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Pain",
"       </td>",
"       <td>",
"        Yes, may be severe",
"       </td>",
"       <td>",
"        Yes, usually mild but may be severe",
"       </td>",
"       <td>",
"        No",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Arterial pulses",
"       </td>",
"       <td>",
"        Absent",
"       </td>",
"       <td>",
"        Present",
"       </td>",
"       <td>",
"        Present or absent",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Sensation",
"       </td>",
"       <td>",
"        Variable",
"       </td>",
"       <td>",
"        Present",
"       </td>",
"       <td>",
"        Absent tactile, pain, temperature and vibratory sensations",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Foot deformities",
"       </td>",
"       <td>",
"        No",
"       </td>",
"       <td>",
"        No",
"       </td>",
"       <td>",
"        Often",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Skin changes",
"       </td>",
"       <td>",
"        <p>",
"         Shiny, taut, loss of hair",
"        </p>",
"        <p>",
"         Dependent rubor of leg and foot that becomes pale with leg elevation",
"        </p>",
"       </td>",
"       <td>",
"        Erythema, brown-blue hyperpigmentation can be spotty or diffuse: \"stasis\" changes; atrophie blanche (white sclerotic areas), edema; dry skin; varicose veins common; if lipodermatosclerosis is present, skin may be bound down; bilateral lower extremities often affected",
"       </td>",
"       <td>",
"        Waxy or shiny, loss of hair, may be taut; dry skin; may have non-pitting edema, especially on dorsal foot",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Reflexes",
"       </td>",
"       <td>",
"        Present",
"       </td>",
"       <td>",
"        Present",
"       </td>",
"       <td>",
"        Absent",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    Ulcers on the foot and leg are most often due to arterial or venous disease, neuropathy, or more than one of these conditions. Although the most common causes of lower extremity ulcers are venous, arterial, and neuropathic, there are other causes (eg, vasculitis). Mixed ulcers are common (eg, arterial-venous, arterial-neuropathic), and characteristics will vary from single etiology ulcers. In particular, diabetic ulcers are often due to peripheral artery disease and neuropathic disease.",
"    <br/>",
"    Duplex ultrasound is indicated in cases of ankle ulceration for detection of venous reflux. Deep venous insufficiency can lead to lateral or medial ulcer locations. In the absence of deep venous insufficiency, a lateral venous ulcer is most frequently associated with small saphenous vein reflux while medial ulcers are associated with greater saphenous vein reflux.",
"    <div class=\"footnotes\">",
"     * Diabetic foot ulcers are often due to both arterial disease (involving the microcirculation as well as large vessels) and neuropathic disease.",
"    </div>",
"    <div class=\"reference\">",
"     Adapted from: Dormandy JA, Rutherford RB. Management of peripheral arterial disease (PAD). TASC Working Group. TransAtlantic Inter-Society Concensus (TASC). J Vasc Surg 2000; 31:S1.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f5_32_5645=[""].join("\n");
var outline_f5_32_5645=null;
var title_f5_32_5646="Whole blood gold concentration";
var content_f5_32_5646=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=RHEUM%2F56558&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=RHEUM%2F56558&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 521px\">",
"   <div class=\"ttl\">",
"    Attainment of steady state blood gold levels",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 501px; height: 293px; background-image: url(data:image/gif;base64,R0lGODlh9QElAeYAAP///4CAgAAAAP+AgIaG/0BAQMDAwP8AAP/AwP9AQHBwcFBQUP8QECAgIBAQEMPD/6CgoDAwMNDQ0JCQkEpK/7CwsP/w8PDw8AAz/+Dg4GBgYP+wsP9QUP8gIP/g4P9gYP9wcP/Q0P+goP8wMICZ/w0N/8DN/0Bm//Hx/+Li/ysr/xwc//+QkGho/6Wl/7S0/zs7/3d3/xBA/yBN/+Dm/6Cz/1lZ/2CA/9DZ/9LS/3CN/5aW//Dz/1Bz/zBZ/7DA/8D/wJCm/4D/gDBQMFCvUKBgYMBBUOABH89AQAkJv0NDgMFBXwA/AIBAQJU2nwAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAACH5BAAAAAAALAAAAAD1ASUBAAf/gACCg4SFhoeIiYqLjI2Oj5CRkpOUlZaXmJmam5ydnp+goaKjpKWmp6ipqqusra6vsLGys7S1tre4ubq7vL2+v8DBwsPExcbHyMnKy8zNzs/Q0dLT1NXW19jZ2tvc3d7f4OHi4+Tl5ufo6err7O3u7/Dx8vP09fb3+Pn6+/z9/v8AAwocSLCgwUwGDFwQdAFCAAgLATR8GPGgxYvJIAgQYEBQBAEFBETwCFIkxpMoWylQICmDg40dKwhYAGCBgAoyadqskLKnz1EFCkgKGrJjAAEBABwNsFQpUkIGmEoN0PGn1auNgkaa4CBDUadJlzZtOijq1AJJsarFCoFoUAdC/yGF3AhzggCWCgRMsItXryKmawP/PEp3Y9xHEhJ+nHAhg4AGBhoIyOAYsuQMf9MK3owxQ8LPBiRQ+goAguQGEASZfpw6M+fXsEsBjk07YGG6h1vNrs2b39sIbzXA2t27eD4HVRUIf0XcuHN6AoRfWJCbVfPn2N/lpatZd/fs4NtNCDoh1vXw6GOfT8/+G09b69vL1/Y4AOZZ8efrr1bB5szWw32334DXZBCAZA4ocJ93BDa4jQEawORKfg5W+MwFE4jGoIUcFkRhhyAGMxddC1S0yochpshLAcAV4MBHAqKCooo03gKZIMppUF0qM9booyzRSURdADvKGOOPSNYSIf93GtC0YZJQ2nIBkQWUJ8GCJx4Z5Zbi9Mjll6GMCFKAYJbJigJEObDchFqa6eYoCjjJ5pt0oqIcmXXm+YmYhs2p55+boOlWASw9Ceihy3iJ6KK6KMroo7U4CumkeFJqaSKUmdfmpZQaAFJVhnIqqkRE+hXqqKhiqYqkqJoJwUt9Mrdpq3++RFShftI6aYK0sKorl3fiN+uvdIpZJI/DEuumoEHheqqy0ILia7RIjrfAe7JSi+h2G2H7rLZvPjXdsUaCC+hNOJKbiFnYTgQRQw6965q5etrEoqmPeModSSGNBMBH/S4yLb0hTicAr5F4VtqYOdV0U8M7zUuwshAs4AD/T2MhlXF3ZkmF1sRvFiABs4ROokAEDqS28cZQTUVksiDTyJGxlWwEAF8A5LXXXTnje8jAMb8ZwAJDPwZAZZFNhvRlEgcN5sc5y+lIBZKBpOFqqKl2GoCIAO30fgY2gFYAwFX6dZT6FgZzKF6DiMAAcMc9AAKoXmBABBokpGG2f74NdwIJwE332aK0rSLcxL6Km9mAIv5rA5K5uOa3dTqu600C5Dy5dWtzaTmtHEUwtLqmGH6Q33LPvcrnpqAu9+D74U2Ys5wbhzrggq8+gCq3B666g3tpmh3rqRCPivHzrdRr52shb4rzpUDPno7LD797K9KPkj16XEnFde3YbR+K//igkJ8dzXw/Z74n63fSvnOJfbY35bS9v4n9muDfmwKtTcC8J6bDiP4wMcBLFBA2dsNbQqjDuOIcsBIPpEQEN5M2umwuS9ZbRQgQsAHAbQABIdCdIjzAggGwIISHEEECUCgIECSgEgkAAQBcqIkQJEAEhLAhDi+hQ12EbWyMaSA7XBc32B3vep+wAAL89oEEjOAAB+gA4KaYgA5AcQQJ+IDgEGCB8SHRECI4AAOqeAAjDmIAZSREAg5QiQO8UARflAQa6YaAA3zRA7+zRB3jKIg9yuJK1YtH73KnigIuEY4uTAADoAg4EJhwiV084xeViIASJhKKY4zhAESwRALyUf8QHjjACCJ5QgCEoIkf6OIcAYAADnDAioVoZQI4QLdTZjGSKvyAGwEAR1YOwAO83N3bNuBKCwwgASwghAfW+AFOHgAETcQhHulmARdyIIR43EATQ9DBDwhChVkMoR/B+YEQ6jJwAKjmLFmICglQp1lCfMcE5fjJQ3iAg3DjgBOvOEu4fRCYjRDfPTeQz32Ksp8D+KcjkMeCA2ygEB5gwAgGIFEAzDGiDBgALAcRyolqMaITregGRInGF67Romk8KRolKkZFHgCgprTiCEBQRzcu8p52BMAIMrpTnLpRjCOwIg45AAIQMKADrMwpUY2K1CdKUacZZQADIomKqsUqV/P/mGckPkdJSwIOk43cZCcNWE9IHHIAiVykGzXJAkgSAnmrhGIZG/pQEBwgBHOkKwBOOogQRBEEONSrXUPAgQN0cZcqTSkb4/rCVZ4xjX606xLt6FcZjrStOT2pH/Ho0qTujrOL9Kwp3XjMNKZiJoGkh1YfQdgpWvGgWpwbF70YCkrCrYlPjOIU6zlSYerybWmco3AVW4gOQlGLwS0jXxG7WOIyFqVGXKUf57hHP1Y3s2zcI0g38ETPbre71iUt3GB6igXQLn1ZLWsS37bGDkjxg+w8xWoZscEOlvWJNP2tX2nZAQZAd6T8ZeMgEPCBDQB4vwjo7wztOFKTsrGhMQzt/3MdKwg0yjan1M3pUVt5Vz9q1o515MAGYHldEZP4ACIGgFQ/OID4lkIDcIEneuUxX2WKAARPnOkGgFnjgKqXFM6zwAcWyQAOAFMEVuxACFdpV/cKGJS5vSYvkxxCC6zxyntlowWeuE/oAmCXFAaAB6xISwyX0Y8heCIDcOjh7GL3qG7e3RrhLIg5m3KNoiSvKdCHVRr/uBKVfOUY8yhJV/SYEYcGUwCzEUELELS9HyhlIhKtCEpP+s/okcBHIlOeGcdjgB4QwQe4DIINUHURlkZEqg+x6pSgDDloiqc73vc2DkiVA4R+RKsLseu3Yjo8NylAVEgnm/+NQ3yOdqEom//p4q3+unzP/kSvMeKA8VDtgqsytjigFwJRWzFwpr5ftNk3bveV2zmEkZCn4UE89t66rdA29LnFbSFreYt+7ECcBzaAY1ECVs/Snrce44a7XD9P4L2pQFIMND/w0QMETg7cbOWLcEoQkZDFq3htGpCWAkjN4fGwQGGlzIppy8LkFuGIIIgka3VsoMiOlLc3UH6QBmjgAhfAW8vPIXIGPBTlNH9F0D1UGFDhuxwv50Akdz1Ig0ej6WacT1uuJbx29PyhhU7FxZ0Oja1HXT7xC83OxZH0U1tU44S7BbfGtG5yXJ3VaE97LQ7mvbF7o+yqjrvcZ8Hx1Jbj7ZfeOzPQJD//u2sD75XWu+BhweejZwPwqFb84l3hkLpHQgJMAZC7IrJ5gWn7GYhHtOQnT4zCFApgJvlXSfyViEUTA/I+Jj0yDIawSKRGAjaD2MNQG7HWf34ZoV/o6GWfipDcy9iVAQtYWOb7b8B+EVAn/jDQlTNiIyJiK3sKWQTRMaZAjRvBZ4TXpS8MByRlOh9vxAVC0j+e6QxnOmvZWX6/ivFD4vnkv8ba782IDACMKZTxGEkTgJYxGU3jC9H3COGXf9hgb5JQQSqHNa0hgZ5nDOuDfwx4DUNzNAXAf9lmgdG2gBl4DSkjCNTTdr6AbLaGdSPIDSqnFNY3Cq5HcY0ggi14DREQ/wE4UXuOlwvSg4E3iA0ysRFdYXi4AD02GITYYCAToCogJwzIA4RK2BMzeHCHkIRTmBJVGD1xJIVZSIX0J3ODgIVfqIVhiD3X44VlaA2DImN9FgyIQ4ZrWA23cVU9eIQgsIJzOA43AgAacIaWsIWkYFdKt4fjYCqxhoK90AEyZIjjYHwfgW3IUgxhNHyOSAwGMxMm8oTA0AETdYmbIYihwAK+A4rf4DKZZ4S0YAEM4Dem6A11yHZv2AvHdHav2A2gUXiKiAusSDdDd4uugHlNWHXAUIu2CIzcoBFE2HAYBAysiEK/iIyq4AALYAAVEAHp94HAAE1ZJ43Z8IIst4u1EP9KMBWN3ngKEcBxCsCDnKgLH+BN3XiO1iABsBIBm9iMvUCOviaP2iB2xMgL78hrlsiPt1B5UsGMk5iPUyWQBMmGdWh02sgL6ORLf+M7X9eQy1AlCUEoDZCNpyCKmYAAC0mRqXORGJkM1PcyMSgtgCgKE3mS2tAA5reORLOSnwCSlyCSZgeT1lABsOIAI9Np7VgLL8mT2WA3EHmHrJBgRmkVOFkJHbBDTQmGuoBkUzkYLekJUXmVPvGUkmCVXGkNsWiTLJkLHcCCYTkNvxEcqogKpJiW2IAcOCKJ5WILvbgZD0AAermXBPAAp5CXfKmXfjkgQTIubfk8L4SXe0kBFCD/mH+5mI3ZlwSydlk5CV7pCHcZG3rpCptZIeNRJf94compmQTAmaVpIf54mKPwjLXRmazgmgRCjxthj6opCtzYmqf5mrlJIJATAOtIlx9ZmZagj+oAmIE5mKkAm6qgnPsBjmR5k8JZCQG5DsbJmI65nLuJnRXSkdaoc5JgNwvSeRIRL/dYCJc5Qi8FD8yJCut5Cu0pH8p4MAi5CAZgE5qBev6CnxUoC9P5Du9ZCv9JCgHKHsLohI2wLwCgezjBe9THfS7zfa8QUTu5DgMqChUaCheKHqkpCWSRfWHxFGXxoNEpCUWpC8bJl8jJntmZnCuqohUimyJRnozQodqnMTXa/ybneQg66QvVGZkp6p4tCqSmqQg8YAI4MAo1cAJHigM9oKT90Ju/aZkgCn96QaVC+TMjCgkl6gsZ+gld6glf2gn/eQMYgAE0IAomQAJnOgMyoKb94JwPGCF5czQCeBlLY4DN9wo7Kgxhygl9ugl/qgn/KQMzgAFBIAg1QAKCQAI1AACJSgOKagJN2gM/AACQ+gM3cAKNCgA4kKk3wAMAkKY0UAMYMANqSgKYqqn4wJ3XCJyIcBtawxqxmjUHuApbyqVBagqBmgm7ignvSao1MAMzIAgngAGCgAEnAADFKgPGSgI3QAKFSgMmUKYnwKw0QAMy4AMkkK0AQAIYYAI6gP8BMnAC04qs1noP8QmUtbkJTEkMvXoJ7zoJOfAAL2CdgXmv+Jqv+rqvjZkIPYABPBCuR1qsx5qsxQqqAMADQdADhWoC06qo4WoCQYABlSqw3moCAICsoYoBEPut+FCgoakKW+muuQqgJXsJKPAAgNkCFAADJVACKsCY9rqvNFuzNNuvh8AD4noCPoABOqCsxpqxBhu0AOADMlADZOqwHNut33qxTJumHquxD/u09ZCLerOumQCWJDukl6CyLkAAMcCYK/CyjBkDBLADKosChBCvldCeE/us0CoDAPCvN0CmQzsIpWoCxaq0inqxOIABPWACbEq1Uru0TgsddficAJT/pYwwslvbCheaAvSqlzbQsi8LAxRgA3r5Ag+QAo7AtpTQnj2LsOH6AzjArOF6t4tapj3Lt1QbrKV6pE5buH3rsfSAig+BtZegtY+rm4SQsg+wA2DLmC+7AmVLAC6gsr56sqMAugi0obNoCmd5DM77CPNarzKrApdLAS0gmA+gtqBQvZEgvoIRn7QpjqDwlpNwonv5o7rKvJUAvHrJsi4LszJLAZybA6tAvo/Av2vhAOoYJOjrCZkpCT16nSyKCV47vBQwtiVwvGj7vWsLvxhKweFrwdkhl9WnuxI0mpbgv40QuZNLAJVbv5iruQTAuZ4bwhgMpi0spi9cHAmhAQow/8MeWZeoUMAfHMOAupvAK7xhSwHFe7zJ676SAMKMgMSLoMQ+MZYcLEcevMOtkAOVy5jaWwKY2719KcEXzLW+SyC4+z34aAqsyas8TAkpSwBCrAIxm7/7e8Zm7MXRcpm3GcejkAIuEAMuCwMx8AKey8SJAMiIIMiHQMhQ4pXEaceeELw2oALGK5mFYMiRDMfLK8fQ4pX9qciYgAIvoMYw2wI7oL+BTMnwSspSDLmmDChPmciaPAl43AIuSwF9DL5JnMqha8uPcMCQXAq6bMTscQFo4k4emJClkMmt7Ah5aQMrsAKa68tLjMtHDM2NwL4ITArUvMv64R8QcsPBaQoSCv/DjsDJYYvFLeACoty20gwJkgwueiFs4Ri9nnCrpawIOeACLaC9jfkCtFzJqGyKwWYAHvfE4jeSfrqiednAzIy2XdzPoAhjACwAYhyRLjl8m5kCL6DHWBwDLrDCFprOi9DLjkh75zXGoLCnnXDP+NyX+yygHq0I1+zMcGmZjLtXo/cAQmwD56ydMV0JbVgyAwxoSMUJKdACK7CXlrzTkODEP00JjrvJBFACLaC26zwIU43UZRkKvHsJLmC8HF3VAODVwAiyAo0ITV0JD8DGPyrJIG3VtkcX6rrUkZDVrtzALlDILZ0IL83WkUCN3cnNpTOi0xu/LVACBLDSVH3Xeh3/CnAK14+gvqG7Ai3A0Xad2MKQjr7JjiStCToMCS4QszAtCGBN2ZIAo+cLz5ZgjJFg0ypQ1yws2sIAvUqJma0YCUNd1OqM2K7NCe50K4dpfxYVxYuAAk8d1eOL27mtCVYli7FNkgU3OGXcCFtNAZLdv8Z93JiAWsJy2nFUxx+N1uhs3bxgXn5HT8qUnouQAnS9vpBZzeAtC0GBMrzN2Ps4CMZsCCgw2IVNCXnd3rSg1KYtehxl3oMM2dPN3wYxLZZT34PQ2RTw2QaeDESSIePtbKBE0ISg2qz94NOQbmoCAQZKzJPgOFta29Wt4bBwARWAJosj34Vm0gAg3FBt2CY+/w1RYYdDKXw0TQjRXeAzHg0ATSLDyOIVNjcjedYq4OA9zgyEsQDzqQkZ4D/DbJ6f9ze7g94rkOFJbg1P7h9qEuWV4BIvwjP72cEdcN+ELeNZbg0BYCueEH8vIaODgOAH4AQEnubaMDJi4teT8BWkEaJnMTa4G+guYwRHkARKIOiInuiKvuiM3uiO/uiQHumSPumUXumTnpRrQRjU6OF7onJ97qCWPhVIsAShPulBUeqSfuqoDumqvuqO3uquzuiwHumYrhYO0eSaEDEfgeuZgHI5GuczXas4nNmHohHXYjTaM5CN8OsrF+x5euPFRinrKBK83uvKPqPO3jXZjqX/Lf+D224pvv7tUt7thSPuhMDsjBLu5M425g7s6342KJcQriDvrUDvrGDvq4DvxGeOdp4P/N7v9/DvAF8PAj/w6WXw6FHwCO8ODdEERQDnpJAYH04KCmcfqQCeg/DkARBEpbChEzHTGs/x3FftEwMEQvARTCASQgAEqiCb5h4hKPOCHW+fgzAirBcKmCeLslkADUAKNi8IOa+40QIERCAAQyAEQyAARMDyqfARIHpaAjAlT08KCJqgOCcZtb4Jc3EYkkHymVABV+/pNp52zCcjCTL1pxAhDZCDEA9AaA8ATDMKnhIXuAc52F0KcT/3k1f2poB7Cvf2pWAXH/HWpYP2OEP/CnoPAJ4SAXcD0YEv5oqv3HJnpTxyG9+Oe0JhF0JPCdvXM666CYmP+coHJwLMfZKfdnc68aDgGRASHar/CY5xMXJ6Cq0/pw7DcVQxChIg+AoB9zexaaNgE7jfEbsvEr0veBRoHYBPCquhJm3PCbAKAJYPFEUHAJp2MBHdCdMvJlm/8N7//eAf/uI//uRf/uZ//uif/uqPDYmxEBiv+N1PCInI+VpxCG3h9evvDHmRFMYOCAAGAhEAhoeIiAUCiY2OhxACCwGKjAABAgaPm5ydnp+goaKjpKWmp6ipqqusra6vsAAVAgUAGgIOlwIKABcBBQsVhhkaBRoSAIu9ARMA/xLFCxCJFQsFzRmLGpqGBg0CAQaYE8XCgtUKFwAQARkTGQbV1gAZARUKBcIV7OoB6bH/AAMKHEiwoMGDCBvhAuAgggAJizRFcBDAoYQMDQM4yKWsgIOLhAJoWIBo1gIFuyR4iyDNEAQHtNbhWiQgg0mUJBfBDKfhlwAIgxpUfBipmYMGCZMqXcq0qdOnBxdFmjUBpjNaIr9NENAz4iJM0iQIaKBggj9DCwSkm6hr2yFlbQGghPctgLdkag1dmLDAIbhvsr5daEgVquHDiBMrXgxw690I3kgOKhCgcjiuldkt8kZJlkdClQwpw+RWtCXSbb9mxnto4oStfykNonTL4ehZxrhz697NW6lYSboENGPoAOgECGIjVDCgAGJNbxIMaFi+ERFsk3ErVZCAmvTWBQYqaGBtaCzzb4O0WRQkAHjv9/Djy5/vCWaz38icpR2bzyEhbIwEJYF/EeR3iAIwLZAOaiXZ110ml3gDHFzqtPdVULi0BIA35dDn4YcghigibrMlcsFYI6ao4oostrhKidYB5uKMNNZo44045qjjjjz26OOPQAYp5JBEFmnkkUgmqeSSTDbp5JNQRinllFRWaeWVWGap5ZZcdunll2CGKeaYZJZp5plopqnmmmy26eabcMYp55x0IhkIADs=);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Mean whole blood gold concentrations in 51 patients treated with gold sodium thiomalate and 59 patients treated with auranofin after 21 weeks of therapy. Higher blood gold concentrations are achieved with conventional doses of gold sodium thiomalate than with auranofin. Gold levels reach a plateau after 6 to 8 weeks of injectable treatment and after 12 weeks of auranofin, reflecting the longer half-life of the oral compound. Bars show standard deviations.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f5_32_5646=[""].join("\n");
var outline_f5_32_5646=null;
var title_f5_32_5647="Slow RNS in LEMS";
var content_f5_32_5647=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=NEURO%2F74605&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=NEURO%2F74605&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Slow repetitive nerve stimulation in Lambert-Eaton myasthenic syndrome",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 394px; height: 298px; background-image: url(data:image/gif;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Slow (3 Hz) repetitive nerve stimulation in Lambert-Eaton myasthenic syndrome, before and after brief exercise. In both situations, there is a prominent decrement. However, after brief exercise, the baseline compound muscle action potential (CMAP) is significantly larger compared with the CMAP before exercise. (Note that the&nbsp;y-axis&nbsp;is in&nbsp;microvolts for stimulation at rest, and in millivolts for stimulation postexercise). In this case, the CMAP increment after brief exercise was 2000 percent.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: Preston DC, Shapiro BE. Electromyography and Neuromuscular Disorders, 2nd ed, Butterworth-Heinemann, Boston 1998. Copyright &copy; 1998 Elsevier.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f5_32_5647=[""].join("\n");
var outline_f5_32_5647=null;
